C-terminal methylation of truncated neuropeptides: An enzyme-assisted extraction artifact involving methanol  by Stemmler, Elizabeth A. et al.
C
e
E
L
a
b
O
c
a
A
R
R
A
A
K
N
M
C
O
M
F
(
N
t
Q
t
c
u
m
i
s
p
R
H
0
hPeptides 46 (2013) 108–125
Contents lists available at SciVerse ScienceDirect
Peptides
j ourna l ho me pa g e: www.elsev ier .com/ locate /pept ides
-terminal  methylation  of  truncated  neuropeptides:  An  enzyme-assisted
xtraction  artifact  involving  methanol
lizabeth  A.  Stemmlera,∗, Elizabeth  E.  Bartona, Onyinyechi  K.  Esonua, Daniel  A.  Polaskya,
aura  L.  Onderkoa,  Audrey  B.  Bergerona,  Andrew  E.  Christieb,1, Patsy  S.  Dickinsonc
Department of Chemistry, Bowdoin College, 6600 College Station, Brunswick, ME 04011, United States
Program in Neuroscience, John W.  and Jean C. Boylan Center for Cellular and Molecular Physiology, Mount Desert Island Biological Laboratory,
ld  Bar Harbor Road, P.O. Box 35, Salisbury Cove, ME  04672, United States
Department of Biology, Bowdoin College, 6500 College Station, Brunswick, ME 04011, United States
 r  t  i  c  l e  i  n  f  o
rticle history:
eceived 8 March 2013
eceived in revised form 17 May  2013
ccepted 18 May  2013
vailable online 25 May  2013
eywords:
europeptide extraction
ethanol
rustacean neuropeptides
rcokinin
atrix assisted laser desorption/ionization
ourier transform mass spectrometry
MALDI-FTMS)
anoelectrospray ionization quadrupole
a  b  s  t  r  a  c  t
Neuropeptides  are  the  largest  class  of  signaling  molecules  used  by nervous  systems.  Today,  neuropeptide
discovery  commonly  involves  chemical  extraction  from  a tissue  source  followed  by  mass  spectrometric
characterization.  Ideally,  the extraction  procedure  accurately  preserves  the  sequence  and  any  inher-
ent  modiﬁcations  of  the native  peptides.  Here,  we present  data  showing  that  this  is  not  always  true.
Speciﬁcally,  we  present  evidence  showing  that,  in  the  lobster  Homarus  americanus,  the  orcokinin  fam-
ily  members,  NFDEIDRSGFG-OMe  and  SSEDMDRLGFG-OMe,  are  non-native  peptides  generated  from
full-length  orcokinin  precursors  as  the  result  of  a highly  selective  peptide  modiﬁcation  (peptide  trun-
cation  with  C-terminal  methylation)  that  occurs  during  extraction.  These  peptides  were  observed  by
MALDI-FTMS  and  LC–Q-TOFMS  analyses  when  eyestalk  ganglia  were  extracted  in a methanolic  solvent,
but  not  when  tissues  were  dissected,  co-crystallized  with  matrix,  and  analyzed  directly  with  methanol
excluded  from  the  sample  preparation.  The  identity  of NFDEIDRSGFG-OMe  was  established  using  MALDI-
FTMS/SORI-CID,  LC–Q-TOFMS/MS,  and  comparison  with  a peptide  standard.  Extraction  substituting
deuterated  methanol  for  methanol  conﬁrmed  that the  latter  is the  source  of  the  C-terminal  methyl group,ime-of-ﬂight mass spectrometry (nanoESI
-TOF MS)
and MS/MS  conﬁrmed  the  C-terminal  localization  of the  added  CD3.  Surprisingly,  NFDEIDRSGFG-OMe  is
not produced  via  a chemical  acid-catalyzed  esteriﬁcation.  Instead,  the methylated  peptide  appears  to
result from  proteolytic  truncation  in  the presence  of  methanol,  as evidenced  by  a reduction  in  conver-
sion  with  the  addition  of  a protease-inhibitor  cocktail;  heat  effectively  eliminated  the  conversion.  This
unusual  and  highly  speciﬁc  extraction-derived  peptide  conversion  exempliﬁes  the  need  to  consider  both
l  pro
© 201  chemical and biochemicaAbbreviations: MALDI-FTMS, matrix assisted laser desorption/ionization Fourier
ransform mass spectrometry; SORI-CID, sustained off-resonance irradiation
ollision-induced dissociation; HPLC Chip–nanoESI Q-TOF MS,  high performance liq-
id  chromatography-Chip nano-electrospray ionization quadrupole time-of-ﬂight
ass spectrometry; LG, lamina ganglionaris; ME,  medulla externa; MI, medulla
nterna; MT,  medulla terminalis; XO, X-organ; SG, sinus gland; SoG/brain, suprae-
ophageal ganglion; STG, stomatogastric ganglion; CoG, commissural ganglion; PO,
ericardial organ.
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1. Introduction
Peptides are the largest class of signaling molecules used by ner-
vous systems to modulate physiology and behavior. Members of
this class of signaling agents can function as locally released neu-
romodulators and/or as circulating hormones. Peptides are initially
synthesized as larger prepro-hormones, which undergo at least one
cleavage, and often extensive post-translational modiﬁcation, prior
to assuming their ﬁnal bioactive conformations [7].
Crustaceans, particularly members of the Decapoda, have a long
history in peptide research [7]. In these animals, mass spectrom-
etry (MS) has played a major role in peptide discovery [20,28].
The MS-based identiﬁcation of neuropeptides from crustaceans has
frequently relied upon matrix assisted laser desorption/ionization
Open access under CC BY-NC-SA license.(MALDI)-based analysis of small tissue samples removed from
an individual animal by microdissection techniques (direct tissue
analysis). Alternatively, peptides can be extracted from single tis-
sues or tissues pooled from many individuals prior to MALDI or
icense. 
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Fig. 1. Schematic diagram of the H. americanus crustacean optic ganglia. Distinct
regions include the retina, the lamina ganglionaris (LG), the medulla externa (ME),
the  medulla interna (MI), the medulla terminalis (MT), the X-organ (XO), and the
sinus gland (SG). The XO is a collection of neurosecretory cells located within the
MT,  which produce hormones that are released to the SG.  The XO and SG are linkedE.A. Stemmler et al. / P
lectrospray ionization (ESI). Regardless of method, the identiﬁ-
ation of novel neuropeptides relies upon the assumption that
he tissue isolation/preparation and/or extraction procedures used
ccurately preserve the sequence and any inherent modiﬁcations
f the native peptides.
One group of crustacean peptides that has been the subject
f extensive MS  investigations is the orcokinin family, members
f which are typiﬁed by an overall length of 13 amino acids
nd the structure NFDEIDRXXXGFX, where X represents a variable
esidue [7]. First described from the crayﬁsh Orconectes limosus
41], members of this peptide family have subsequently been
dentiﬁed from many crustacean species (summarized in [7]),
ith many members identiﬁed by MS-based analysis. In most
rustaceans, multiple orcokinins are present, all derived from a
ommon prepro-hormone, which is also the source of a vari-
ty of peptides in addition to the orcokinins. For example, in
he American lobster Homarus americanus, the orcokinin precur-
or protein contains the orcokinins NFDEIDRSGFGFN (3 copies),
FDEIDRSGFGFH (2 copies) and NFDEIDRSGFGFV (2 copies), as
ell as one copy each of FDAFTTGFGHN (commonly referred to
s ocomyotropin), SSEDMDRLGFGFN (an orcokinin-like peptide),
PIKVRFLSAIFIPIAAPARSSPQQDAAAGYTDGAPV, GDYDVYPE, VYG-
RDIANLY and SAE [10].
In recent MS-based analyses of H. americanus neural tis-
ues, each of the full-length orcokinins was detected, as were
DAFTTGFGHN, SSEDMDRLGFGFN, GDYDVYPE, and VYGPRDIANLY
10]. In addition, a number of truncated orcokinin and orcokinin-
ike peptides were characterized in this study [10] and in studies
y other researchers [4,6,10,27,40]. Surprisingly, in studies con-
ucted by Li and colleagues, several truncated orcokinins seemingly
ot derived from the known full-length peptides, i.e. NFDEIDRS-
FA and SSEDMDRLGFA, were characterized [30]; NFDEIDRSGFA
as also been sequenced via MS-analysis from the crab Cancer
orealis [21], where it too does not correspond to any of the
nown full-length orcokinin isoforms. Given this discrepancy, we
ecame interested in determining the origin of NFDEIDRSGFA
nd SSEDMDRLGFA in the lobster. In the data that follow, we
resent evidence showing that extraction with acidiﬁed methanol
ields the C-terminally methylated peptides NFDEIDRSGFG-OMe
nd SSEDMDRLGFG-OMe, and ﬁnd no evidence to support the
etection of NFDEIDRSGFA and SSEDMDRLGFA in H. americanus,
uggesting that these peptides have been mis-identiﬁed. Using
igh resolution MALDI-Fourier transform mass spectrometry mea-
urements, sustained off-resonance irradiation collision-induced
issociation (SORI-CID), high performance liquid chromatography-
hip nano-electrospray ionization quadrupole time-of-ﬂight mass
pectrometry (HPLC Chip–nanoESI Q-TOF MS), and isotopic label-
ng, we also show that methylation at the C-terminus of these
runcated peptides arises as the result of a highly selective pep-
ide modiﬁcation during neuropeptide extraction from certain
rustacean tissue samples in the presence of methanol, a solvent
ommonly used for peptide extraction. Furthermore, we show
hat this modiﬁcation is not a simple chemical artifact, but rather
s likely an enzymatically mediated process involving methanol.
aken collectively, the data presented in this study demonstrate the
eed to consider that unexpected neuropeptide modiﬁcations may
ccur in the process of neuropeptide extraction from tissue sam-
les, giving rise to artifactual isoforms that can be misconstrued as
aturally occurring, native isoforms.
. Materials and methods.1. Animals and tissue collection
American lobsters, H. americanus, were purchased from local
uppliers (Brunswick and Harpswell, ME,  USA) and maintained inby the sinus gland tract (sgt). The optic nerve (optn) connects the eyestalk to the
supraesophageal ganglion (SoG).
aerated seawater tanks at 8–10 ◦C. Prior to dissection, animals were
anaesthetized by packing in ice for approximately 30 min. After
icing, the eyestalk ganglia were isolated via manual microdissec-
tion in chilled (8–10 ◦C) physiological saline. For some experiments,
eyestalk ganglia were divided in a regional speciﬁc manner to allow
for analysis of the individual regions of this system, i.e. the medulla
terminalis (MT), which includes the X-organ (XO), the medulla
interna (MI), the medulla externa (ME), the lamina ganglionaris
(LG), and the sinus gland (SG), a neuroendocrine organ derived from
the XO somata (Fig. 1). Techniques used for the isolation of entire
stomatogastric ganglion (STG) and commissural ganglion (CoG), or
small pieces of the supraesophageal ganglion (brain), or pericardial
organ (PO) have been described [10,11].
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poration, Scotch Plain, NJ, USA) was  mixed with 30 L of10 E.A. Stemmler et al. / P
.2. Sample preparation for direct tissue MALDI-FTMS analysis
For direct tissue MALDI-FTMS, dissected tissues were rinsed
equentially in two 12 L droplets of 0.75 M d-fructose solution
reagent grade; Fisher Scientiﬁc, Pittsburgh, PA, USA) and placed on
 face of a ten-faceted probe tip, minimizing co-transfers of solu-
ion. The tissue was then sliced 10–20 times with a 0.2 mm minuten
in, gathered together, and covered with a 0.5 L droplet of 1.0 M
,5-dihydroxybenzoic acid [DHB; Sigma–Aldrich (sublimed prior to
se)] prepared in 1:1 acetonitrile:water containing 2% phosphoric
cid.
.3. Tissue extraction
.3.1. Extraction with methanol:water:acetic acid
For most extractions in acidiﬁed methanol, the extraction sol-
ent was 30% deionized water, 65% methanol (CH3OH; HPLC-grade;
isherbrand), and 5% glacial acetic acid (CH3CO2H; reagent grade;
igma–Aldrich, ≥99%), as a %[v/v] mixture. A single eyestalk gan-
lion was rinsed sequentially in two 12 L droplets of 0.75 M
-fructose solution, placed in a 0.6 mL  low retention centrifuge tube
Fisherbrand) with 50 L of extraction solvent (smaller volumes
ere used when smaller tissues were analyzed), and then homog-
nized by one of the following methods. In early work, the tissue
as repeatedly sliced with spring scissors; in most of the work
eported in this study, tissues were ground by inserting a longer,
maller diameter polypropylene tube (0.25 mL;  Fisherbrand) into
he 0.60 mL  tube and repeatedly twisting the tube for homogeniza-
ion. In some experiments, deuterated methanol (CD3OD; 99.8%
euterated; Cambridge Isotope Laboratories, Andover, MA,  USA)
as substituted for the standard CH3OH in the extraction buffer
the same solvent composition was used). After tissue homoge-
ization, the sample was sonicated for 2–5 min  and centrifuged
t 15k rpm for 5–15 min. The supernatant was removed from the
ample and placed in another 0.6 mL  tube. In early experiments,
amples were delipidated prior to analysis. For delipidation, 25 L
f nanopure water was added to the supernatant along with 25 L
hloroform (NMR-grade 13CDCl3; Cambridge Isotope Laboratories)
n order to remove lipids from the aqueous solution. The two
ayers were sonicated for 2 min  and centrifuged for 10 min. The
ottom organic layer was removed. Chloroform was added and
he extraction was repeated two more times, but with a 5-min
entrifugation.
The aqueous layer was either stored at −20 ◦C or concentrated
o dryness in a SpeedVac vacuum concentrator (UVS400 Univer-
al Vacuum System, Thermo Electron Corporation) at 36 ◦C. Once
ried, the extract was reconstituted to a total volume of 50 L in
:1 ACN:H2O in preparation for analysis by MALDI-FTMS or HPLC
hip–nanoESI Q-TOF MS.  For some samples analyzed by MALDI-
TMS, the extracts, reconstituted in 0.1% TFA water, were desalted
sing C18 ZipTip pipette tips (Millipore, Billerica, MA,  USA). For
ALDI-FTMS analysis of extracts, 0.5 L of the extract was  mixed
ith 0.5 L of DHB matrix on one face of the MALDI probe and the
xtract–matrix mixture was allowed to co-crystallize.
.3.2. Extraction with acetone:water:hydrochloric acid or
aturated DHB
For extractions in acidiﬁed acetone (85% acetone
Sigma–Aldrich, ≥99%], 13% deionized water, and 2% HCl [reagent
rade; Fisherbrand], as a %[v/v] mixture, a single eyestalk ganglion
as rinsed sequentially in two 12 L droplets of 0.75 M d-fructose
olution and placed in a 0.6 mL  low retention centrifuge tube
Fisherbrand) with 50 L of extraction solvent. The tissue was
round by inserting a longer, smaller diameter polypropylene tube
0.25 mL;  Fisherbrand) into the 0.60 mL  tube and repeatedly twist-
ng the tube for homogenization. After tissue homogenization, thes 46 (2013) 108–125
sample was sonicated for 2–5 min  and centrifuged at 15k rpm for
5–15 min. The supernatant was  removed from the sample and
dried prior to being reconstituted in 1:1 ACN:H2O in preparation
for analysis by MALDI-FTMS.
For extraction in saturated DHB, the extraction protocol
described above was  followed, using 50 L of a freshly prepared,
saturated solution of DHB in deionized water as the extraction
solvent.
2.3.3. Extractions with protease inhibitors
Paired eyestalk ganglia were dissected from individual lob-
sters, with the ganglion from one eyestalk used as a control and
the ganglion from the second used as a test to determine if a
protease inhibitor cocktail, included in the extraction protocol,
reduces or eliminates the C-terminal methylation reaction. The
protease inhibitor cocktail was  prepared by dissolving one tablet
(complete, Mini; Roche Applied Science, Indianapolis, IN, USA) in
1.5 mL  deionized water to prepare a stock solution, which was
further diluted 1:7 with deionized water. In initial experiments,
the control eyestalk tissue was homogenized in normal extraction
solvent (65:30:5, methanol:water:acetic acid), while the test eye-
stalk tissue was homogenized in extraction solvent in which water
had been replaced with protease inhibitor cocktail solution. After
homogenization, the tissues were sonicated for 5 min, centrifuged
for 15 min, and the supernatant was removed from the tissue pellet.
In later experiments, the control tissue was ﬁrst homogenized and
sonicated in 30 L of nanograde water; the test tissue was homog-
enized and sonicated in 30 L protease inhibitor cocktail solution.
Then, 65 L of methanol and 5 L of glacial acetic acid were
added to each tube. The samples were resonicated and centrifuged;
the supernatant was then removed from the tissue pellet. Most
samples were dried and subjected to ZipTip puriﬁcation prior to
analysis.
2.3.4. Extractions with heat
Paired eyestalk ganglia were dissected from individual lobsters,
with the ganglion from one eyestalk used as a control and the gan-
glion from the second used to test the effect of submerging the
tissue in boiling water prior to homogenization. Each tissue was
placed in 50 L of normal extraction solvent. The control tissue
sample sat at room temperature for 5 min; the test tissue sample
was placed in a boiling water bath for 5 min. The two samples were
then homogenized, sonicated, centrifuged and the supernatant was
removed from the tissue pellet.
2.3.5. Liquid nitrogen freezing of tissues
Prior to the standard tissue extraction procedure detailed above,
the ganglion from one eyestalk was immediately placed in a beaker
of liquid nitrogen with forceps for 15 s in order to freeze the
tissue. The tissue was then placed in a 0.6 mL microcentrifuge
tube and homogenized by grinding with a smaller centrifuge
tube. Then 30 L of extraction solvent was  added to each tis-
sue sample and the tissues were then extracted as described
above.
2.4. Standards with extraction solvent
To determine whether methyl esteriﬁcation occurs with syn-
thetic standards, 2 L of 10−3 M [Asn13]-orcokinin or Orc[1-11]
(NFDEIDRSGFGFN or NFDEIDRSGFG, respectively; GenScript Cor-either CH3OH:water:acetic acid (65:30:5), CD3OD:water:acetic
acid (65:30:5), or nanopure water. The solutions sat at room tem-
perature for 23 h before they were dried, reconstituted with 25 L
1:1 ACN:water, and analyzed by MALDI-FTMS.
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.5. [Ala13]-orcokinin standard added to tissue and extraction
olvent
To determine whether an exogenous orcokinin peptide under-
oes truncation and C-terminal methylation, 1 nmol of a synthetic
Ala13]-orcokinin standard (NFDEIDRSGFGFA, a gift from Drs. L. Li
University of Wisconsin-Madison] and E. Marder [Brandeis Uni-
ersity]) was added to two 0.6 mL  microcentrifuge tubes, each
ontaining 50 L of extraction solvent [CH3OH:water:acetic acid
65:30:5)]. The ﬁrst tube contained only the solvent and standard;
o the second tube, one eyestalk ganglion was added and homog-
nized. Both samples were sonicated for 5 min  and centrifuged for
5 min; the solvent fraction was then analyzed by MALDI-FTMS.
he solvent in the tissue-containing samples was analyzed with-
ut separating the supernatant from the tissue pellet. An additional
 nmol of the [Ala13]-orcokinin standard was added to the tis-
ue/extraction solvent mixture, and the sample was resonicated
nd centrifuged and analyzed before and after sitting at room tem-
erature overnight.
.6. Tryptic digestion of NFDEIDRAAFGFA in methanolic buffer
To determine whether C-terminal methylation can compete
ith hydrolysis by trypsin, 1 nmol of NFDEIDRAAFGFA was  mixed
ith 0.09 nmol of bovine trypsin (Sigma–Aldrich) in 25 mM,
H = 4.0, citrate buffer prepared with water or 25% methanol. The
igestion proceeded at room temperature for 1–4 days with anal-
sis by HPLC Chip–nanoESI Q-TOF MS.
.7. Instrumentation
.7.1. MALDI-FTMS
Most samples were analyzed using a HiResMALDI Fourier trans-
orm mass spectrometer (Varian, Lake Forest, CA, USA) with a
ryomagnetics (Oak Ridge, TN, USA) 4.7 Tesla actively shielded
uperconducting magnet. Ions were generated using a pulsed nitro-
en laser (337 nm)  and were transported from the external ion
ource to the closed cylindrical ICR cell using a quadrupole ion
uide. The ion guide radio frequency potential and trapping delay
ime were optimized to transmit and trap ions of a selected mass
ange (optimized for m/z 1500 for the results presented here).
 pulse of argon was introduced to the vacuum system during
rapping to elevate the system pressure transiently for collisional
ooling. All spectra were measured using ion accumulation tech-
iques, where ions from 7 to 30 successive laser shots were
ccumulated in the cell. A delay of 5–10 s preceded ion detection,
hich occurred with analyzer pressures of 1–2 × 10−10 Torr. Trans-
ents (4 or 10 s) from direct tissue spectra were apodized using
 Blackman function and zero-ﬁlled prior to fast Fourier trans-
ormation; SORI-CID spectra (see below) were processed without
podization.
Mass spectra were calibrated using the m/z values for two
reviously identiﬁed peptides [2]: APSGFLGMRamide (C. bore-
lis tachykinin-related peptide I [CabTRP I]; m/z  = 934.4927) and
YRKPPFNGSIFamide (Val1-SIFamide; m/z  = 1423.7845). Peaks for
hese two peptides were present in the spectra and served as inter-
al calibrants.
For SORI-CID experiments, argon was used as the collision gas,
he frequency offset was set to −1.8% of the reduced cyclotron fre-
uency and the voltage amplitude was in the range of 6–8.5 Vbp.
ORI-CID spectra were calibrated externally, with a one-point
djustment based upon a [MH−NH3]+ fragment mass. The stan-
ards NFDEIDRSGFGA and NFDEIDRSGFG-OMe were characterized
y SORI-CID.s 46 (2013) 108–125 111
2.7.2. HPLC Chip–nanoESI-Q-TOF MS
Mass spectrometric analysis was performed using a 6530
quadrupole time-of-ﬂight (Q-TOF) mass analyzer (Agilent Tech-
nologies, Santa Clara, CA). Mass spectra (MS  and MS/MS)
were collected in positive ion mode; the ionization voltage
ranged from 1850 to 1950 V and the ion source tempera-
ture was held at 350 ◦C. Spectra were internally calibrated
using methyl stearate (C17H35CO2CH3) and hexakis(1H, 1H, 4H-
hexaﬂuorobutyloxy)phosphazine (HP-1221; C24H18O6N3P3F36),
continuously infused and detected as [M+H]+. CID-MS/MS exper-
iments were executed with precursor ions subjected to CID using
nitrogen as the target gas with the collision energy set to 26 V. Chro-
matographic separation and nano-electrospray ionization (ESI)
were performed using a 1260 Chip Cube System (Agilent Technolo-
gies) using a ProtID-chip with a 40 nL enrichment column and a 43
or 150 mm × 75 m analytical column (Agilent Technologies). The
enrichment and analytical columns were packed with 300 A˚, 5 m
particles with C18 stationary phase. The mobile phases were 0.1%
formic acid/H2O (A) and 0.1% formic acid/acetonitrile (B). Samples
(0.2–2 L) were loaded on the enrichment column using 98:2 (A:B)
at 4 L/min. Tryptic digest samples were analyzed with the 43 mm
analytical column using a gradient of 98:2 (A:B) to 20:80 (A:B) over
a period of 12 min  at 0.6 L/min. Eyestalk extracts and peptide stan-
dards were analyzed with the 150 mm  analytical column using a
linear gradient of 98:2 (A:B) to 65:35 (A:B) over a period of 5 min,
to 40:60 (A:B) at 25 min  and 2:98 (A:B) at 35 min  using a ﬂow rate
of 0.3 L/min.
2.8. Data analysis and ﬁgure production
Calibrated mass spectral peak lists were generated using the
Omega 8.0 software (IonSpec, Lake Forest, CA, USA). MALDI-FTMS
ﬁgures were generated using the Boston University Data Analysis
software (B.U.D.A.; provided by Dr. Peter O’Connor, University of
Warwick, Department of Chemistry, Coventry, England) to produce
graphics that were imported into CorelDRAW X4 for ﬁnal ﬁgure
production. HPLC Chip–nanoESI Q-TOF MS  ﬁgures were generated
by exporting Mass Hunter (Agilent) chromatograms or mass spec-
tra as metaﬁles and importing these graphics into CorelDRAW X4
for ﬁnal ﬁgure production.
3. Results
The paired eyestalks of the lobster, H. americanus, and other
crustaceans are composed of several distinct regions (shown
schematically in Fig. 1) that contain unique complements of neuro-
peptides [18]. Only the SG of H. americanus has been characterized
by mass spectrometry [6,8,10,15,30], and this tissue has been found
to be a rich source of crustacean neuropeptides. This study was
originally initiated in an attempt to more fully characterize the
complement of neuropeptides present in different regions of H.
americanus optic (eyestalk) ganglia, using MALDI-FTMS and the
direct analysis of tissue samples, complemented by the analysis
of tissue extracts. For this study, the analysis of tissue extracts was
needed to characterize tissues that were too large to be fully charac-
terized directly. We  also planned to extract and analyze entire optic
ganglia to obtain a full measure of the neuropeptide components.
For the extraction of neuropeptides from tissue samples, we used
an approach applied in previous studies in our lab, which involved
microdissection of the desired tissue, tissue homogenization in
a methanolic solvent mixture (65:30:5, methanol:water:glacial
acetic acid for the work reported here), followed by sonication
and centrifugation prior to MALDI-FTMS analysis. In early experi-
ments, samples were delipidated with chloroform. This step, which
112 E.A. Stemmler et al. / Peptides 46 (2013) 108–125
Fig. 2. (A) A summary of H. americanus full-length ([Asn13], [His13], and [Val13])
and truncated (Orc[1-12] and Orc[1-11]) orcokinin family peptides relevant to
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Fig. 3. MALDI-FT mass spectra of H. americanus eyestalk tissue and tissue extracts.
(A)  Spectrum from a small piece of freshly dissected tissue from the XO/MT  region
of the eyestalk. (B) An expansion of spectrum (A) showing the region where the
peaks at m/z 1270.56 and 1253.54 ([M+H]+ and [MH−NH3]+ from an orcokinin family
peptide) would appear, if detected. (C) Spectrum of XO/MT tissue extracted with
methanol:water:acetic acid (65:30:5). (D) Entire eyestalk ganglion extracted with
methanol:water:acetic acid (65:30:5). All spectra were measured using DHB  as the
matrix and conditions optimized for m/z 1500. Spectra were calibrated using known
peptide peaks [42], including APSGFLGMRamide (CabTRP) and VYRKPPFNGSIFamide
(Val1-SIFamide) at m/z 934.4927 and m/z 1423.7845, respectively. The peaks at m/z
1270.57, 1253.54, 894.43, 876.42, and 537.28 (labeled with ﬁlled circles) in (C) and
(D) were attributed to an orcokinin family peptide that was not detected in directly
analyzed tissues, such as (A); peaks for Orc[1-11] at m/z 1256.55, 1239.53, 862.41,his study. (B) A summary of ions produced from orcokinin family peptides
ia  metastable decomposition upon analysis by vacuum UV-MALDI-FTMS or by
ORI-CID.
id not impact our results, was eliminated for most work reported
ere.
In previous studies, we have used MALDI-FTMS to analyze
ndividual H. americanus SGs directly, or following single tissue
xtraction of a single gland [10]. A comparative analysis of neuro-
eptide proﬁles for each mode of sample preparation showed good
greement in terms of the neuropeptides detected and their rela-
ive abundance. Our work [10,43] and reports by other researchers
6,15,30] have consistently shown that orcokinin family peptides
re abundant neuropeptides present in this tissue. A summary
f the full-length orcokinin family peptides ([Asn13]-, [His13]-,
nd [Val13]-orcokinin) predicted by molecular cloning [10] and
bserved in our previous work with H. americanus appears in
ig. 2A. Two additional peptides encoded by the orcokinin gene
nd detected by mass spectrometry are the orcomyotropin peptide
DAFTTGFGHN (m/z 1213.53) and the orcokinin-related peptide
SEDMDRLGFGFN (m/z 1474.63). Additional truncated orcokinins,
ncluding Orc[1-12] and Orc[1-11] (Fig. 2A) have been observed
ass spectrometrically in our lab [10,43] and by other researchers
6,15,30,40].
An important aspect of the work described below is an appre-
iation of the nature of the neuropeptide signals produced on our
ALDI-FTMS instrument, which is particularly relevant to the iden-
iﬁcation of orcokinin family peptides. As described in previous
ublications [10,43], orcokinin family peptides produce a unique
ass spectral signature, characterized by the fragment ions sum-
arized in Fig. 2B, when analyzed by our vacuum UV-MALDI-FTMS
nstrument. The mass spectral signature is a consequence of the
rcokinin amino acid sequence, which incorporates a basic, pro-
on sequestering, arginine (R) residue and two acidic aspartate
D) residues. When a peptide sequence containing this amino acid
ombination is coupled with the energy imparted by the vac-
um UV-MALDI ionization and the long trapping times required
or FTMS analysis (>10 s), singly protonated orcokinin family pep-
ides undergo so-called “Asp-Xxx cleavages” [47], which result
n the production of characteristic C-terminal (y-type) fragments
see Fig. 2B). Our identiﬁcation of orcokinin family peptides by
ALDI-FTMS relies on the detection of both the [M+H]+ ion and theand 523.26 are labeled with ﬁlled triangles.
observation of characteristic y-type ions resulting from Asp-Xxx
cleavages.
3.1. MALDI-FTMS analysis of eyestalk tissue extracts shows an
orcokinin family peptide not predicted by genomics
When we analyzed small pieces of eyestalk ganglion tissues
directly by MALDI-FTMS, we  detected neuropeptide peak pro-
ﬁles that reﬂected differential distributions of neuropeptides in
localized regions of the eyestalk ganglia. For example, the pep-
tides CabTRP I (APSGFLGMRamide at m/z 934.49) and Val1-SIF
(VYRKPPFNGSIFamide at m/z 1423.78) were detected in tissues
from the LG, XO/MT, MI,  and ME but not in the SG. Orcokinin family
peptides were detected in many tissues, including the XO/MT, MI,
ME,  and SG. A representative spectrum from a small piece of XO/MT
tissue is shown in Fig. 3A.
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Fig. 4. SORI-CID of the [M+H]+ ion at m/z 1270.57 detected in a H. americanus eye-
stalk extract, compared with spectra derived with peptide standards, shows better
agreement with that derived from the NFDEIDRSGFG-OMe standard; however, the
spectrum for NFDEIDRSGFA is also very similar. (A) The SORI-CID mass spectrum
of  the m/z 1270.57 peak originating from the MALDI-FTMS analysis of a H. ameri-
canus eyestalk ganglion extract. (B) The SORI-CID mass spectrum of the [M+H]+, m/z
1270.57 peak produced from an Orc[Ala11] standard. (C) The SORI-CID mass spec-
trum of the [M+H]+, m/z 1270.57 peak produced from an Orc[1-11]-OMe standard.
Each m/z 1270.57 peak was  dissociated following ion isolation. Argon was used asE.A. Stemmler et al. / P
In contrast with previous studies [10], where we  found good
greement between single tissues analyzed directly and by single
issue extraction, our analysis of extracts of tissues from the afore-
entioned regions of the eyestalk ganglion revealed the presence
f a new peptide that had not been detected by direct tissue MALDI-
TMS. For example, Fig. 3C shows the spectrum observed when a
mall piece of XO/MT tissue was removed by microdissection tech-
iques, placed in extraction solvent, homogenized, sonicated, and
entrifuged. While we continue to detect peaks for CabTRP I and
al1-SIF, an abundant signal at m/z 1270.57 was  observed, which
as detected in combination with additional peaks showing the
haracteristic orcokinin family pattern. The full collection of peaks
ppeared at m/z 1270.57, 1253.54, 894.43, 876.42, and 537.28;
hese peaks were assigned to [M+H]+, [MH−NH3]+, yn+4, yon+4,
nd yn+1. Unexpectedly, these masses did not correspond to any
rcokinin family members predicted from genomic information for
. americanus [10], nor did they correspond to masses expected
rom conventional post-translational modiﬁcations, including the
runcation of full-length orcokinin family peptides. Instead, exact
ass measurements (m/z 1270.5692, measured) were consis-
ent with the orcokinin sequence, NFDEIDRSGFA (Orc[Ala11]; m/z
270.5699, predicted). This peptide has been detected in other
tudies [4,16,19,30,31] with the ﬁrst characterization, from the
rab, C. borealis, reported in a study by Huybrechts et al. [21];
ater reports include the detection of Orc[Ala11] in nervous sys-
em tissues and neuroendocrine organs from H. americanus [30].
hile C-terminally truncated versions of full-length H. ameri-
anus orcokinin-family peptides, including Orc[1-12] and Orc[1-11]
Fig. 2A), detected in XO/MT extract (Fig. 3C) and direct tissue
Fig. 3A and B) spectrum, have been also been reported by our
aboratory [10] and by other researchers [4,6,10,27,40], the alanine-
ontaining peptide sequence is unusual because an alanine residue
t this position is not known for any full-length orcokinins detected
ass spectrometrically or predicted from genomic information.
When we analyzed the extract from an entire eyestalk ganglion,
e again detected peaks for the m/z 1270.57, putative Orc[Ala11],
eptide (see Fig. 3D). To ensure that the detection of this peptide
as not the result of a mutation speciﬁc to the individual animal
nalyzed, localized tissue samples and entire eyestalk ganglia from
dditional individuals (n > 30) were extracted. Although the abun-
ance of the m/z 1270.57 and other putative Orc[Ala11]-derived
eaks varied relative to that of other detected peptides, signals for
his peptide were consistently observed, except in extracted sinus
land samples, where these signals were weak or missing.
.2. MALDI-FTMS with SORI-CID supports the identiﬁcation of
FDEIDRSGFG-OMe, not NFDEIDRSGFA
To further characterize the amino acid sequence of the peptide
ppearing at m/z  1270.57, we subjected the peak to analysis by
ORI-CID, the form of MS/MS  used on our FTMS instrument. Isola-
ion of the [M+H]+ at m/z  1270.57 from an eyestalk ganglion extract
ollowed by SORI-CID yielded a spectrum showing an abundant
eak at m/z 1253.54 (loss of NH3) and the production of y-type
equence ions, including the Asp-Xxx cleavage products at y8, yo8,
nd y5 (m/z 894.43, 876.42, and 537.28, respectively; see Fig. 4A).
his experiment provided support for our assignment of the m/z
270.57 peak as an ionized orcokinin family peptide and, further-
ore, supported our attribution of the m/z 1253.54, 894.43, 876.42,
nd 537.28 peaks in the MALDI-FT mass spectrum of tissue extracts
o this gas-phase precursor. However, the SORI-CID mass spectrum
id not provide sufﬁcient information to establish the full amino
cid sequence.
In previous studies [43], we have shown that the variable C-
erminal sequence of orcokinin-family peptides can be established
y using the mass spectrometric isolation and dissociation of thethe collision gas with an excitation amplitude of 6.5 Vbp. The y-type fragment ions
are identiﬁed using the nomenclature established by Roepstorff [36].
yn+1 fragment by SORI-CID. The yn+1 fragment, produced via Asp-
Xxx cleavage, contains the arginine (R) residue at the N-terminus
and yields b-type sequence ions, which retain the N-terminal,
arginine-containing, end of the peptide sequence. When the y5
peak at m/z 537 was isolated and subjected to SORI-CID interro-
gation, we measured peaks, including b1, b2-NH3, b3, and b4 at m/z
157.11, 227.11, 301.16, and 448.23, respectively, that are consistent
with the sequence RSGF (Fig. 5A). Other peaks in the spectrum (m/z
472.23, 489.26, 502.24) resulted from combinations of small neu-
tral molecule losses (NH3, H2O, and CH2O). Working from the mass
of the b4 ion, the remaining mass (89.047 Da) is accounted for by
an alanine (A) residue (71.037 Da) and water (18.011 Da), consis-
tent with the sequence for putative Orc[Ala11]; however, we were
surprised that the mass spectrum did not show a [b4+H2O]+ prod-
uct ion at m/z 466.24. The [bn+H2O]+ ion is a C-terminal fragment
that we have detected at >30% abundance in the SORI-CID spectra
of yn+1 ions derived from many orcokinin family peptides, includ-
ing Orc[1-12] [43], [Val13] [43], and [Ala13] (data not shown). The
absence of this characteristic peak led us to question the sequence
assigned to putative Orc[Ala11].
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Fig. 5. SORI-CID of the y5 ion at m/z 537.28 detected in H. americanus eye-
stalk extracts, and the comparison with spectra derived from peptide standards,
demonstrates that the tissue-derived peptide sequence is NFDEIDRSGFG-OMe, not
NFDEIDRSGFA. (A) The SORI-CID mass spectrum of the m/z 537.28 peak originat-
ing  from the MALDI-FTMS analysis of a H. americanus eyestalk ganglion extract,
showing no evidence for a [b4+H2O]+ ion at m/z 466.24. (B) The SORI-CID mass
spectrum of the y5 peak at m/z 537.28, which was produced from an Orc[Ala11]
standard. The spectrum shows the [b4+H2O]+ ion at m/z 466.24, which is generated
by fragmentation of peptides with a free acid at the C-terminus. (C) The SORI-CID
mass spectrum of the [M+H]+, m/z 537.28, y5 peak produced from an Orc[1-11]-
OMe  standard. The [b4+H2O]+ ion at m/z 466.24 is absent because methylation of
the C-terminus blocks the rearrangement [45] required for ion formation. Each m/z
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n37.28 peak was dissociated following ion isolation. Argon was used as the collision
as with an excitation amplitude of 6.5 Vbp. The y- and b-type fragment ions are
dentiﬁed using the nomenclature established by Roepstorff [36].
To more conclusively establish if the m/z  1270.57 peptide is,
n fact, Orc[Ala11], we measured SORI-CID mass spectra for a syn-
hetic form of the peptide. As shown in Fig. 4B, SORI-CID of the m/z
270.57, [M+H]+, peak yields a spectrum that closely resembles that
f the eyestalk extract-derived peptide; however, we  note that the
ntensity of the y8 peak (m/z 894.43) for the standard (Fig. 4B) is
onsistently lower than that observed for the putative Orc[Ala11]
eptide (Fig. 4A). While this mass spectral difference was  repro-
ucible, the fact that the mass spectrum is dominated by Asp-Xxx
leavage ions (y8, yo8, and y5) limited our ability to carry out a more
etailed comparison of structural features. In contrast, SORI-CID of
he y5 peak at m/z 537.28 proved to be more revealing. While simi-
ar ions and ion intensities were detected in the lower m/z  range of
he spectrum, more signiﬁcant differences in ion intensities and
on identity were observed at higher m/z  values (Fig. 5B). Most
otably, the SORI-CID spectrum of the Orc[Ala11]-derived y5 peaks 46 (2013) 108–125
(Fig. 5B) shows an abundant [b4+H2O]+ product ion at m/z  466.24,
which was  not detected in the spectrum of the eyestalk extract-
derived peptide (Fig. 5A). Production of the [b4+H2O]+ ion from the
Orc[Ala11]-derived y5 ion is congruent with predicted fragmen-
tation behavior, based upon studies of other orcokinin peptides
(described above). The fact that this peak is not detected in the
spectrum of putative Orc[Ala11] provides deﬁning evidence that
our eyestalk extract-derived peptide is not Orc[Ala11].
Furthermore, when structural elements that would block for-
mation of the [b4+H2O]+ ion are considered, we  are able to
propose a sequence for the eyestalk-derived m/z 1270.56 orcokinin
peptide. Speciﬁcally, the mechanism responsible for the produc-
tion of [bn−1+H2O]+ product ions has been investigated, and it
is known that ion formation involves a rearrangement at the
C-terminus that requires a free C-terminal carboxyl group [45].
This rearrangement is prevented when the C-terminus is blocked
by amidation or esteriﬁcation. Based upon this information, we
hypothesized that the m/z 1270.57, eyestalk extract-derived pep-
tide was  not Orc[Ala11], but was, instead, NFDEIDRSGFG-OMe (also
m/z 1270.57), a C-terminally truncated orcokinin that has been
speciﬁcally methylated at the C-terminus. To test this hypothesis,
we carried out the SORI-CID characterization of synthetic Orc[1-
11]-OMe (Figs. 4C and 5C). The SORI-CID mass spectra for both the
m/z 1270.57 (Fig. 4C) and 537.28 (Fig. 5C) peaks derived from syn-
thetic Orc[1-11]-OMe showed excellent agreement with spectra
from the eyestalk extract-derived peptide (Figs. 4A and 5A), par-
ticularly with respect to the absence of the diagnostic [b4+H2O]+
ion, which provided strong support for our hypothesis regarding
the identity of this peptide.
3.3. LC/MS analysis of tissue extracts provides additional support
for the identiﬁcation of Orc[1-11]-OMe, not Orc[Ala11], based
upon chromatographic retention times
To provide further evidence in support of our identiﬁcation of
Orc[1-11]-OMe, we  analyzed the extract from a single H.  amer-
icanus eyestalk tissue by HPLC Chip–nanoESI Q-TOF MS  (Fig. 6A
and B). Under the same chromatographic conditions, we analyzed
standards of Orc[Ala11] (Fig. 6C) and Orc[1-11]-OMe (Fig. 6D). The
analysis of the eyestalk extract revealed the presence of a sin-
gle peak at 16.5 min  in the extracted ion chromatogram (EIC) for
the m/z 635.789, [M+2H]2+, ion for the isobaric Orc[1-11]-OMe or
Orc[Ala11] (Fig. 6B). A comparison with the retention times for
the Orc[Ala11] (Fig. 6C) and Orc[1-11]-OMe (Fig. 6D) standards
showed that Orc[1-11]-OMe elutes at the same time as the eye-
stalk extract peptide (16.5 min), while Orc[Ala11] elutes at an earlier
time (15.5 min). The enhanced retention for Orc[1-11]-OMe rela-
tive to Orc[Ala11] is expected given the higher hydrophobicity of the
C-terminal ester group compared with that of the free acid. Addi-
tional conﬁrmation of our identiﬁcation of putative Orc[1-11]-OMe
was provided by enriching the eyestalk sample with Orc[1-11]-
OMe  standard and observing signal enhancement at the retention
time for the eyestalk peak at 16.5 min  (data not shown). These
experiments provided additional support for our identiﬁcation of
Orc[1-11]-OMe in eyestalk tissue extracts.
3.4. Q-TOF-CID analysis yields MS/MS spectra that are not useful
for distinguishing Orc[1-11]-OMe and Orc[Ala11]
While LC retention times proved to be diagnostic for distinguish-
ing Orc[1-11]-OMe and Orc[Ala11], CID experiments carried out
by HPLC Chip–nanoESI Q-TOF MS  yielded MS/MS  spectra for the
two standard and the eyestalk-extract peptide that were virtually
indistinguishable (see Fig. 7A, E, and G). In contrast with SORI-CID
mass spectra of these compounds, where dissociation of the m/z
1270.56, [M+H]+ precursor ions (Fig. 4A–C) provided very limited
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Fig. 6. Chromatograms from HPLC Chip–nanoESI Q-TOF MS analyses, which show
the H. americanus eyestalk ganglion-derived peptide eluting at the same time as
NFDEIDRSGFG-OMe, not NFDEIDRSGFA. (A) Total ionization chromatogram (TIC)
for  a single eyestalk ganglion extracted with methanol:water:acetic acid (65:30:5).
(B–D) Extracted ion chromatograms (EICs) for the m/z = 635.789, [M+2H]2+, ion char-
acteristic of isobaric Orc[1-11]-OMe and Orc[Ala11]. (B) EIC of the extract from a
single H. americanus eyestalk ganglion showing a single peak that elutes with the
same retention time as Orc[1-11]-OMe. (C) EIC for an Orc[Ala11] standard, which
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Fig. 7. HPLC Chip–nanoESI Q-TOF MS/MS  spectra showing that Q-TOF  MS/MS
spectra are not useful for distinguishing the isobaric peptide sequences
NFDEIDRSGFG-OMe and NFDEIDRSGFA, but do provide support for the sequence and
C-terminal localization of the added methyl group when the peptide NFDEIDRSGFG-
OCD3 is produced by extraction in CD3OD-containing solvent. (A) CID-MS/MS
spectra for the m/z = 635.789, [M+2H]2+, ion characteristic of isobaric Orc[1-11]-
OMe and Orc[Ala11] for the H.  americanus eyestalk ganglion-derived peptide eluting
at  16.5 min; single eyestalk ganglion extracted with CH3OH:water:acetic acid
(65:30:5). (B) Expansion of (A) showing m/z 85–95. (C) CID-MS/MS spectra for the
m/z = 637.298, [M+2H]2+, ion characteristic of Orc[1-11]-OCD3 for the H. americanus
eyestalk ganglion-derived peptide eluting at 16.5 min; single eyestalk ganglion
extracted with CD3OD:water:acetic acid (65:30:5). Filled stars show peaks that have
shifted by 3.02 Da as a result of the incorporation of CD3. (D) Expansion of (C) show-
ing m/z 85–95. The ﬁlled star indicates that the y1 sequence ion has shifted by
3.02 Da, demonstrating that the CD3 group has been incorporated at the C-terminus.
(E) CID-MS/MS spectrum for the m/z = 635.789, [M+2H]2+, ion from the Orc[Ala11]
standard eluting at 15.5 min. (F) Expansion of (E) showing m/z 85–95. (G)  CID-MS/MS
spectrum for the m/z = 635.789, [M+2H]2+, ion from the Orc[1-11]-OMe standard
eluting at 16.5 min. (H) Expansion of (G) showing m/z  85–95. All CID-MS/MS spectra
were acquired using a collision energy of 26 V, nitrogen as the collision gas, and a
4  Da window for ion isolation. The CID-MS/MS spectrum for the eyestalk-derived
peptide, extracted using CH3OH (A and B) is indistinguishable from the spectra for
Orc[Ala11] (E and F) and Orc[1-11]-OMe (G and H); however, the eyestalk-derived
peptide, extracted using CD3OD (C and D) shows y-series ions, including y1 (see (D)),lute with a shorter retention time than Orc[1-11]-OMe. (D) EIC for an Orc[1-11]-
Me  standard. EICs were generated using a 15 ppm mass window.
equence information as a consequence of proton localization by
he charge-sequestering arginine residue, dissociation of the m/z
35.79, [M+2H]2+, precursor ions on the Q-TOF instrument yielded
S/MS  spectra that provided excellent sequence coverage through
he formation of y- and b-type ions (see Fig. 7A, E, and G); however,
he MS/MS  spectra still precluded structural differentiation because
roduct ion masses were identical (Ala and G-OMe are isobaric) and
he structurally similar residues did not inﬂuence relative ion inten-
ities in ways that were useful for distinguishing the two peptide
equences.
.5. Methanol in the extraction solvent is the source of added
ethyl group
Because our extraction solvent contains 65% methanol, the
ethanolic solvent was hypothesized to play a role in the pro-
uction of Orc[1-11]-OMe. To determine if this was  the case, we
arried out tissue extractions using CD3OD, instead of CH3OH,
n the extraction solvent. To eliminate variations that may  result
hen comparing tissues extracted from different individuals, the
aired eyestalk tissues were removed from one lobster. One eye-
talk ganglion was placed in extraction solvent containing CH3OH
nd the other in extraction solvent containing CD3OD. The samples
ere homogenized, sonicated, and centrifuged, and the super-
atant was separated from the tissue pellet. The samples were
ried and reconstituted for analysis by MALDI-FTMS. The MALDI-FTthat are all shifted by 3.02 Da, demonstrating methylation at the C-terminus and pro-
viding conﬁrmation of the Orc[1-11]-OMe sequence. The y- and b-type fragment
ions are identiﬁed using the nomenclature established by Roepstorff [36].
mass spectra for the two  eyestalk tissue extracts show that the
Orc[1-11]-OMe-derived peaks at m/z 1270.57, 1253.54, 894.43,
876.42, and 537.28 for the eyestalk extracted with CH3OH (Fig. 8A
and B) have all shifted by 3 Da to m/z 1273.59, 1256.56, 897.45,
879.44, and 540.30, for the eyestalk extracted with CD3OD (Fig. 8C
and D).
MALDI-FT mass spectra and CID experiments carried out on the
Q-TOF also support our localization of the added methyl group at
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Fig. 8. Methanol in the extraction solvent is the methyl group source for Orc[1-11]-
OCH3. MALDI-FT mass spectra for H. americanus eyestalk ganglia extracted using
(A) methanol extraction solvent (65:30:5; CH3OH:H2O:CH3CO2H) or (B) deuter-
ated methanol extraction solvent (65:30:5; CD3OH:H2O:CH3CO2H). All spectra were
measured using DHB as the matrix; conditions were optimized for m/z 1500. Spectra
were calibrated using known peptide peaks [42], including CabTRP and Val1-SIF at
m/z 934.4927 and m/z 1423.7845, respectively. The peaks at m/z 1270.57, 1253.54,
894.43, 876.42, and 537.28 from Orc[1-11]-OMe (A) shift by 3 Da for the spec-
trum generated using CD3OD-containing solvent (B), demonstrating that the added
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aethyl group originates from the methanolic solvent. Orc[1-11]-OMe peaks labeled
ith ﬁlled circles; peaks for Orc[1-11] at m/z 1256.55, 1239.53, 862.41, and 523.26
re labeled with ﬁlled triangles.
he C-terminus of the peptide. This localization is supported by the
 Da mass shifts for the y8, y08, and y5 ion in the MALDI-FT mass
pectra of eyestalks extracted with CD3OD (Fig. 8), which localizes
he added methyl group to the C-terminal sequence, and by the
 Da mass shift for y-type (but not b-type) ions produced in the Q-
OF MS/MS  analysis (Fig. 7C and D). The most diagnostic fragment
s the y1 peak, which undergoes a 3 Da mass shift (from m/z = 90.06
o 93.07) for the CD3-labeled peptide (Fig. 7D). This fragment ion
eﬁnitively localized the methyl addition to the C-terminus. These
esults document the incorporation of one CD3 group for Orc[1-
1]-OMe at the C-terminus and demonstrate that the methanolic
xtraction solvent is the source of the added methyl group.
.6. Methylation is a biochemical, not chemical, extraction
rtifact
Acid-catalyzed esteriﬁcations have been recognized as the
ource of exogenous protein methylations that occur when
ethanol and acids are used, for example, in destaining SDS-
AGE gels [5,17,24,48]. In an early study by Haebel et al. [17], ﬁve
est peptides were incubated in methanolic trichloroacetic acid
TCA) solutions (12.5:50:37.5, methanol:TCA:water) for 1–24 h to
etermine the propensity for methylation at different amino acid
esidues. The authors concluded that glutamate (E) undergoes the
ost rapid acid-catalyzed esteriﬁcation, the C-terminus reacts with
 rate that is lower by a factor of 2–6, and other groups (D, Q) ares 46 (2013) 108–125
less reactive by at least a factor of 10 [17]. When acetic acid replaced
TCA, methylation was  not observed [17].
A direct chemical modiﬁcation appeared to be unlikely as an
explanation for the production of Orc[1-11]-OMe under our condi-
tions, based upon the following observations and considering the
work by Haebel et al. [17]. First, our data clearly show that meth-
ylation occurs, with 100% speciﬁcity, at the C-terminus. It seems
unlikely that an acid-catalyzed chemical conversion could account
for this highly speciﬁc methylation, which leaves the remaining two
aspartate and the single glutamate residues unmodiﬁed. Second,
we ﬁnd no evidence for methylation of any full-length orcokinin
family peptides. Third, we ﬁnd that signiﬁcantly lower levels
of Orc[1-11]-OMe are found in extracts from the SG (a neuro-
peptide storage site) compared with extracts of whole eyestalk
ganglia or small pieces of eyestalk tissue, such as the XO/MT,
where enzymes important for the synthesis and processing of
neuropeptide prohormones are expected to be co-localized. Based
upon these observations, we hypothesized that methylation must
involve processing components endogenous to the eyestalk tissues.
To ﬁrst establish that orcokinin family peptides are not meth-
ylated in vitro by exposure to our extraction solvent, we added
30 L of extraction solvent (CH3OH and CD3OD versions) or 30 L
of water (used as a control) to [Asn13] and Orc[1-11] standards
(2 nmol). [Asn13]-orcokinin was tested because this peptide is an
abundant orcokinin family peptide in H. americanus. Orc[1-11] was
included as the unmethylated form of Orc[1-11]-OMe, to deter-
mine if the sequence of this peptide, including the C-terminal
glycine residue, makes it particularly susceptible to acid-catalyzed
C-terminal methylation. The solutions sat at room temperature
for 24 h, at which time each sample was dried, reconstituted,
and subjected to MALDI-FTMS analysis. The spectra for both
[Asn13]-orcokinin and Orc[1-11] showed no evidence for pep-
tide methylation (data not shown), indicating that the extraction
solvent, alone, is not responsible for the observed peptide modiﬁ-
cation. In addition, we found no evidence for peptide degradation
(truncation or other modiﬁcations).
To test the hypothesis that components endogenous to the eye-
stalk tissues play a role in the C-terminal methylation, we carried
out an experiment in which we started with two  microcentrifuge
tubes, each containing 1 nmol of a standard of [Ala13]-orcokinin, a
full-length orcokinin that is not present in H. americanus. To one
tube we added extraction solvent; to the other we added extrac-
tion solvent and a freshly dissected eyestalk ganglion. The tissue
sample was homogenized and both samples were sonicated and
centrifuged. As expected, the [Ala13]-orcokinin standard alone gave
a strong MALDI-FTMS signal with characteristic orcokinin family
fragments (see Fig. 9A) and showed no evidence for methylation.
In contrast, the MALDI-FT mass spectrum for the tissue-containing
sample showed abundant signals for Orc[1-11]-OMe (Fig. 9B) that
were more intense than Orc[1-11]-OMe signals observed for other
eyestalk tissue extracts. No signals for [Ala13]-orcokinin were
observed. The fact that no [Ala13]-orcokinin signals were observed,
coupled with the elevated Orc[1-11]-OMe signals, suggests that
[Ala13]-orcokinin was converted to Orc[1-11]-OMe in the sample.
To provide more evidence to support this conclusion, we  added
an additional 1 nmol of the [Ala13]-orcokinin standard to the tis-
sue with extraction solvent mixture, resonicated and centrifuged
the sample and immediately analyzed the supernatant by MALDI-
FTMS. With the second addition of [Ala13]-orcokinin, we were
now able to detect peaks for this peptide (see Fig. 9C). When the
mixture was  allowed to remain at room temperature overnight
and was reanalyzed, we  found that signals for [Ala13]-orcokinin
had decreased, while those for Orc[1-11]-OMe had increased (see
Fig. 9D), providing additional support for the conversion of the full-
length [Ala13]-orcokinin to Orc[1-11]-OMe when the methanolic
solvent was  present with a tissue sample. These results are also
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Fig. 9. An exogenous orcokinin peptide, NFDEIDRSGFGFA ([Ala13]-orcokinin), is converted to Orc[1-11]-OMe when added to a tissue extract, but not when exposed to the
extraction solvent alone. MALDI-FT mass spectra for (A) NFDEIDRSGFGFA ([Ala13]-orcokinin standard (1 nmol) in 30 L of extraction solvent. (B) [Ala13]-orcokinin standard
(1  nmol), homogenized in 30 L of extraction solvent with the ganglia from one H. americanus eyestalk prior to analysis. (C) [Ala13] standard (1 nmol) added to the solution
from  (B) and re-homogenized prior to analysis, (D) Solution from (C) after sitting at room temperature for 12 h. All spectra were measured using DHB as the matrix with
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onsistent with our observation that stronger signals for Orc[1-
1]-OMe are correlated with reduced intensities for full-length
rcokinin peptides, an observation that is explained by the con-
ersion of the full-length peptides to the truncated, C-terminally
ethylated form. Taken collectively, these results demonstrate
hat the methanolic extraction solvent alone is not responsible
or the formation of C-terminally methylated Orc[1-11], and point
o components, possibly enzymes, present in the tissue samples
hat facilitate the formation of Orc[1-11]-OMe from full-length
rcokinin precursors.
.7. Enzyme inhibitors reduce Orc[1-11]-OMe formation
To determine if enzymes play a role in promoting the forma-
ion of Orc[1-11]-OMe during extraction of eyestalk tissues, we
ttempted to reduce methylation by inhibiting enzymatic activ-
ty using a commercial protease inhibitor cocktail that contains a
ixture of inhibitors designed to protect against a broad range of
roteases. To include the protease inhibitor in our extraction proto-
ol, we used two different approaches. The ﬁrst approach involved
ncluding the aqueous inhibitor solution in place of water in our
xtraction solution. The second approach involved homogenizing
he tissue in either the aqueous inhibitor solution or water (as a
ontrol), followed by the addition of acidiﬁed methanol to bring
he solvent to the percentages that have been used in previous
xperiments. Experiments were carried out with paired eyestalk
anglia to directly compare the efﬁcacy of the inhibitor treat-
ent.
Our results show that the inclusion of protease inhibitor cock-
ails reduced the detected levels of Orc[1-11]-OMe compared
ith control measurements. For example, Fig. 10A shows the sig-
als from Orc[1-11]-OMe for a control eyestalk ganglion, which
as treated by homogenization in water before the addition
f acidiﬁed methanol; Fig. 10B shows the result when homog-
nization took place in the protease inhibitor cocktail. Both
amples, following sonication and centrifugation, were dried andcles; Orc[1-11]-OMe peaks labeled with ﬁlled circles. Spectra were calibrated using
845, respectively. Peaks for Orc[1-11] at m/z 1256.55, 1239.53, 862.41, and 523.26
puriﬁed using C18 ZipTips to remove salts that interfered with
our ability to produce good quality MALDI-FT mass spectra. As
shown in Fig. 10B and C, only weak Orc[1-11]-OMe signals were
detected in the sample with protease inhibitor present, while
signals from this peptide were abundant when the sample was
prepared without the inhibitor cocktail. We  also noticed that
signals for Orc[1-11] were also reduced with inclusion of the
inhibitor cocktail. Upon carrying out multiple trials making use
of the inhibitor cocktail, we consistently found reduced levels
of both Orc[1-11]-OMe and Orc[1-11] when the inhibitor was
present; however, inhibition was  never complete. Regardless,
these results provide evidence to support the hypothesis that an
enzyme participates in production of the Orc[1-11]-OMe prod-
uct.
3.8. Heat treatment signiﬁcantly reduces Orc[1-11]-OMe
formation; treatment with liquid N2 does not
Heat has been used an effective means to reduce proteolytic
degradation of proteins when processing vertebrate tissue sam-
ples [9,12,13,44]. Working from the hypothesis that an enzyme
plays a role in promoting the formation of Orc[1-11]-OMe during
extraction of eyestalk tissues, we  attempted to deactivate enzy-
matic components with heat. To test this approach we removed
the paired eyestalk ganglia from one lobster. The ganglion from a
single eyestalk was placed in a microcentrifuge tube with 50 L
of extraction solvent and the tightly capped tube was placed in a
boiling water bath for 5 min. Concurrently, the ganglia from the
second eyestalk of the same lobster were placed in extraction sol-
vent and left at room temperature for 5 min. Both eyestalk tissue
samples were then homogenized, sonicated, and centrifuged prior
to MALDI-FTMS analysis.While the control eyestalk extract showed the Orc[1-11]-OMe-
derived peaks at m/z 1270.57, 1253.54, 894.43, 876.42, and 537.28
(see Fig. 11A), no evidence for these peaks was  found for the tis-
sue/extraction solvent mixture that was placed in the boiling water
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Fig. 10. MALDI-FT mass spectra of extracts from a matched pair of H. americanus eye-
stalk ganglia showing that extraction with protease inhibitors reduces the intensity
of Orc[1-11]-OMe and Orc[1-11]-derived peaks, suggesting that enzymatic activity
plays a role in production of this methylated peptide. (A) Control ganglion. The gan-
glion was  homogenized in 30 L of nanopure water, after which 65 L of methanol
and  5 L of acetic acid were added and the sample was sonicated and centrifuged
prior to analysis. (B) Test ganglion, with protease activity inhibited. The ganglion
was  homogenized in 30 L of a protease inhibitor cocktail, after which 65 L of
methanol and 5 L of acetic acid were added and the sample was sonicated and cen-
trifuged prior to analysis. Only low intensity peaks for Orc[1-11]-OMe are detected
for  the extraction was  carried out with the protease inhibitor cocktail. All spectra
were measured using DHB as the matrix and conditions optimized for m/z 1500.
Orc[1-11]-OMe peaks labeled with ﬁlled circles; Orc[1-11] peaks are labeled with
ﬁlled triangles. Spectra were calibrated using known peptide peaks [42], includ-
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Fig. 11. MALDI-FT mass spectra of extracts from a matched pair of H. americanus
eyestalk ganglia, showing that heating the tissue in extraction solvent eliminates
Orc[1-11]-OMe-derived peaks, suggesting that heating effectively deactivates pro-
teases. (A) Control ganglion. The ganglion was  placed in 50 L of extraction solvent
(65:30:5; CH3OH, H2O, CH3CO2H), which sat at room temperature for 5 min, after
which the sample was  homogenized, sonicated, and centrifuged prior to analysis.
(B)  Test ganglion; with heat treatment. The ganglion was  placed in 50 L of extrac-
tion solvent (65:30:5; CH3OH, H2O, CH3CO2H). The capped microcentrifuge tube
was  placed in a boiling water bath for 5 min, after which the sample was homog-
enized, sonicated, and centrifuged prior to analysis. No peaks for Orc[1-11]-OMe,
isobaric Orc[Ala11], or Orc[1-11] are detected for the extraction was carried out after
boiling water heat treatment. All spectra were measured using DHB as the matrix
and  conditions optimized for m/z 1500. Orc[1-11]-OMe peaks labeled with ﬁlledng  CabTRP and Val1-SIF at m/z 934.4927 and m/z 1423.7845, respectively. Peaks
or  Orc[1-11] at m/z 1256.55, 1239.53, 862.41, and 523.26 are labeled with ﬁlled
riangles.
ath for 5 min  (Fig. 11B and C). We  also did not detect the trun-
ated peptide, Orc[1-11]. When this approach was replicated (n > 6),
he treatment consistently eliminated the production of Orc[1-11]-
Me  and Orc[1-11].
We  also tried freezing eyestalk ganglion tissues in liquid nitro-
en before homogenizing and adding extraction solvent, but found
hat this treatment did not measurably reduce production of Orc[1-
1]-OMe.
.9. Lower water content in the extraction solvent reduces
rc[1-11]-OMe formation; acetic acid promotes formation of
rc[1-11]-OMe over Orc[1-11]
Many enzymes are known to function in aqueous-methanolic
olvent mixtures [2,38]; however, enzymatic activity is gener-
lly reduced or eliminated when the water content is reduced
22,25]. We  hypothesized that, if an enzyme plays a role in the
roduction of Orc[1-11]-OMe, production of the peptide would
e reduced if the extraction solvent contained a lower per-
entage of water. To determine if the percentage of water in
he extraction solvent inﬂuenced the extent of methylation, we
xtracted eyestalk ganglia in solvents containing 1–30% water. Thecircles. Spectra were calibrated using known peptide peaks [42], including CabTRP
and Val1-SIF at m/z 934.4927 and m/z 1423.7845, respectively.
mixtures tested included our normal extraction solvent (65:30:5;
methanol:water:glacial acetic acid), a solvent mixture (90:5:5;
methanol:water:glacial acetic acid) containing a lower percentage
of water, and the solvent mixture (90:1:9; methanol:water:glacial
acetic acid) routinely used by the Li group [30] and used by
Huybrechts and co-workers [21]. Experiments were again carried
out with paired eyestalk ganglia to determine directly how the
change in solvent composition impacted the methylation of tis-
sues from a single animal. For these and additional experiments
in which the percentage of water was  held below 1%, we found
detectable, but lower, yields of the Orc[1-11]-OMe product (data
not shown).
Solution pH is an important determinant of enzymatic activ-
ity. Acidiﬁed aqueous and organic solvents are commonly used
to extract neuropeptides from tissue samples [20]; however, a
reduction in solution pH has also been found to promote methanol-
ysis over hydrolysis reactions for enzymes that can function in
methanolic solutions [3]. To determine if the addition of acid to
the extraction solvent plays a role in the formation of Orc[1-11]-
OMe, we  carried out eyestalk ganglion extractions in the absence
of acetic acid, using 65:35, methanol:water. When the eyestalk
ganglion extract was  analyzed by MALDI-FTMS, the peptide Orc[1-
11]-OMe was not detected. Instead, we  observed elevated signals
for the truncated orcokinin, Orc[1-11] (see Fig. 12), which would
be produced by the hydrolysis, not methanolysis, of a full-length
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Fig. 12. MALDI-FT mass spectrum of an extract from an H. americanus eyestalk gan-
glion, showing that eliminating acetic acid from the extraction solvent promotes
hydrolysis (formation of Orc[1-11]) over methanolysis (formation of Orc[1-11]-
OMe), suggesting that pH plays a role in methanolysis. The ganglion was  placed
in  50 L of extraction solvent (65:35; CH3OH, H2O) and was  homogenized, soni-
cated, and centrifuged prior to analysis. No peaks for Orc[1-11]-OMe are detected
for  the extraction was  carried without acetic acid in the extraction solvent. All
spectra were measured using DHB as the matrix and conditions optimized for
m/z 1500. Orc[1-11] peaks are labeled with ﬁlled triangles. Spectra were cali-
brated using known peptide peaks [42], including CabTRP and Val1-SIF at m/z
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Fig. 13. Chromatograms from the HPLC Chip–nanoESI Q-TOF MS  analysis of a tryptic
digestion of synthetic peptide NFDEIDRAAFGFA in (A) pH = 4 citrate buffer and (B)
25% CH3OH, pH = 4 citrate buffer, demonstrating that, under appropriate conditions,
a  serine protease can accommodate methanol as a competing nucleophile and gen-
erate a product methylated at the C-terminus. Peaks 1 (NFDEIDR) and 3 (AAFGFA)
result from tryptic cleavage C-terminal to the arginine residue. Peak 4 is the undi-34.4927 and m/z 1423.7845, respectively. Peaks for Orc[1-11] are labeled with ﬁlled
riangles.
rcokinin. Collectively, these experiments provide evidence that
he percentage of water, as well as solution pH, play a role in
he putative enzymatic conversion of orcokinin family peptides to
ydrolyzed or methylated, truncated forms.
.10. Trypsin-catalyzed C-terminal methylation at low pH is
emonstrated for NFDEIDRAAFGFA
To further test the hypothesis that an enzyme is responsible for
he formation of Orc[1-11]-OMe, and that methanolysis can com-
ete with proteolysis at acidic pH values that are not optimal for
nzymatic activity [3], we carried out the proteolysis of NFDEI-
RAAFGFA, a synthetic peptide, with and without 25% methanol
n a pH = 4, 25 mM citric acid buffer. We  used trypsin as a repre-
entative serine protease that should permit methanol to act as a
ompeting nucleophile in the proteolysis reaction [2,38]. Following
eaction, the products were analyzed by Chip–nanoESI Q-TOF MS.  In
he control experiment (no methanol present), trypsin cleaved the
eptide C-terminal to the arginine residue to produce two  hydrol-
sis products, NFDEIDR and AAFGFA (see Fig. 13A). In the presence
f methanol, C-terminal methylation was observed through the
ormation of NFDEIDR-OMe (see Fig. 13B). No other methylated
roducts were observed.
.11. An additional truncated, methylated peptide,
SEDMDRLGFG-OMe, is identiﬁed
To determine if additional methylated peptides were present
n eyestalk extracts, we compared spectra of eyestalks extracted
ith CH3OH with those extracted with CD3OD and searched for
eptides that showed the predicted shift of 3 Da. This analysis
esults in the identiﬁcation of the peptide SSEDMDRLGFG-OMe,
hich showed peaks at m/z  1227.53, 809.40, and 563.33 ([M+H]+,
7, and y5, respectively). Exact mass measurements (1227.5298,
easured; 1227.5310, predicted) supported this assignment. This
eptide is presumably derived from the full-length precursor SSED-
DRLGFGFN.gested peptide. Peak 2 results from C-terminal methylation when methanol was
present in the solvent, forming NFDEIDR-OCH3. Samples were digested for 3 days
at  room temperature; starting peptide concentration was 2 × 10−6 M.
3.12. Eyestalk ganglia extractions using non-methanolic solvents
fail to provide evidence for Orc[Ala11]
Our analysis of H. americanus eyestalk tissue extracts provided
structural characterization of Orc[1-11]-OMe and demonstrated
that this peptide is not endogenous to H. americanus eyestalk
tissues. The isobaric peptide Orc[Ala11] has been localized to H.
americanus eyestalk ganglion and sinus glands by Li and co-workers
[30]. The fact that Orc[1-11]-OMe is isobaric with previously
reported Orc[Ala11] lead us to wonder whether Orc[Ala11] was
misidentiﬁed in previous studies or if Orc[Ala11] is a neuropeptide
endogenous to the lobster eyestalk ganglia. Misidentiﬁcation is a
possibility, especially when considering the fact that most MS/MS
measurements would not reveal a structural difference between
the two peptides (described above). To address these concerns, we
attempted to detect Orc[Ala11] using eyestalk extracts prepared
using two non-methanolic extraction techniques, namely, extrac-
tion using HCl-acidiﬁed acetone [49] and extraction with aqueous,
saturated DHB [37]. These solvent systems should preclude the for-
mation of Orc[1-11]-OMe and reveal any Orc[Ala11] that may  have
been overshadowed by Orc[1-11]-OMe, particularly if that pep-
tide was  present at higher abundance. These approaches should
then provide two additional measures, complementing our data
on heat-deactivated methanolic extractions where no evidence for
Orc[Ala11]/Orc[1-11]-OMe was  found (see Fig. 11B). In measure-
ments with acidiﬁed acetone (see Fig. 14) and saturated DHB (data
not shown), where we  extracted single eyestalk ganglia from a min-
imum of three individuals, no peaks characteristic of Orc[Ala11]
were detected by MALDI-FTMS.
120 E.A. Stemmler et al. / Peptide
Fig. 14. MALDI-FT mass spectrum of an extract from an H. americanus eyestalk gan-
glion, showing that extracting the tissue in a non-methanolic solvent eliminates
Orc[1-11]-OMe-derived peaks and fails to reveal peaks from Orc[Ala11]. The gan-
glion was placed in 50 L of extraction solvent (85:13:2; acetone:H2O:HCl) and was
homogenized, sonicated, and centrifuged prior to analysis. No peaks for Orc[1-11]-
OMe  or isobaric Orc[Ala11] are detected for the extraction was carried out after
acetone extraction. All spectra were measured using DHB as the matrix and condi-
tions optimized for m/z 1500. Spectra were calibrated using known peptide peaks
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m42], including CabTRP and Val1-SIF at m/z 934.4927 and m/z 1423.7845, respec-
ively. Peaks for Orc[1-11] at m/z 1256.55, 1239.53, 862.41, and 523.26 are labeled
ith ﬁlled triangles.
.13. Sinus gland and CoG extractions with full methyl
steriﬁcation fail to provide evidence for Orc[Ala11]
Because Orc[Ala11] was previously detected in the SG and stom-
togastric nervous system of H. americanus [30], we carried out
 detailed reexamination of MALDI-FTMS spectra generated using
xtracts from single sinus glands and paired commissural ganglia
CoGs), which were reported in a previous study from our labo-
atory [10]. In this study, sinus glands and CoGs were analyzed by
ALDI-FTMS using direct tissue analysis, analysis of methanolic tis-
ue extracts, and analysis of methyl-esteriﬁed tissue extracts. The
ast method of sample preparation, in particular, allows the dif-
erentiation of Orc[1-11]-OMe and Orc[Ala11]. Speciﬁcally, while
rc[1-11]-OMe undergoes a mass shift to m/z  1312.62 following
cid-catalyzed methyl esteriﬁcation of the two aspartate and single
lutamate residues, any Orc[Ala11], with a free C-terminal car-
oxylic acid, would undergo a mass shift to m/z 1326.63 resulting
rom the esteriﬁcation of four, not three, acidic residues. A careful
eexamination of these previously acquired data [10] showed no
eaks characteristic of Orc[1-11]-OMe/Orc[Ala11] for direct tissue
nalysis, low abundance peaks in some, but not all, sinus gland
nd CoG extracts, low abundance peaks m/z = 1312.62 in some,
ut not all, sinus gland and CoG methyl esteriﬁed, and no peaks
haracteristic of methyl esteriﬁed Orc[Ala11] at m/z = 1326.63 in
he methyl esteriﬁed extracts. Subsequent extraction of a single
inus gland using 65% CD3OD:30% H2O:5% acetic acid showed that
he peaks detected for Orc[1-11]-OMe/Orc[Ala11] were shifted in
ass by 3 Da, indicating that the low abundance peptide is Orc[1-
1]-OMe (data not shown). These results again failed to reveal any
ndogenous Orc[Ala11] in the sample.
.14. LC/MS analyses of heat-deactivated, pooled, eyestalk tissue
xtracts fail to show evidence of Orc[Ala11]
To determine if our analysis of single, not pooled, eyestalk
anglion extracts was limiting our ability to detect signals from
ow abundance, endogenous Orc[Ala11], we analyzed pooled
xtracts of 11 and 35 heat-treated, H. americanus eyestalk gan-
lia that were extracted with the solvent composition (90:1:9;
ethanol:water:glacial acetic acid) used in previous studies [21,30]s 46 (2013) 108–125
where Orc[Ala11] was detected. To further increase the dynamic
range for the detection of Orc[Ala11], we analyzed the extracts by
HPLC Chip–nanoESI Q-TOF MS.  When we analyzed data for the
pooled extracts and generated EICs for the m/z  635.789, [M+2H]2+,
ion for the isobaric Orc[1-11]-OMe or Orc[Ala11], a single peak,
eluting at the retention time characteristic of Orc[1-11]-OMe, was
observed (data not shown). We found no evidence for a peak at the
retention time for Orc[Ala11].
3.15. Direct-tissue analysis by MALDI-FTMS reveals no peaks for
Orc[1-11]-OMe/Orc[Ala11] in H. americanus neuroendocrine
organs and tissues
When we initially embarked upon our study of localized regions
of H. americanus eyestalk tissues, we detected peaks attributed to
Orc[1-11]-OMe in extracted tissue samples, but not in any eyestalk
tissues analyzed directly by MALDI-FTMS. Because methanol is not
used as a tissue washing solvent or as a matrix solvent in our pro-
tocol for the preparation of direct tissue samples, we felt conﬁdent
that Orc[1-11]-OMe formation would be prevented during direct
tissue analyses. To further explore the possibility that Orc[Ala11]
is an endogenous neuropeptide in the H. americanus eyestalk gan-
glion, we analyzed additional localized SG, LG, XO/MT, MI and ME
eyestalk tissue samples dissected from a minimum of three indi-
viduals using direct tissue MALDI-FTMS to determine if sampling
variability or differences between individuals could be responsi-
ble for our inability to detect putative Orc[Ala11]. Furthermore, we
collected between three and ten spectra from different regions of
each MALDI sample to account for heterogeneity within each sam-
ple. In the case of SGs, a source of putative Orc[Ala11] in a previous
study, we have collected direct tissue spectra from more than 30
individuals. A representative MALDI-FT mass spectrum from a H.
americanus SG gland is shown in Fig. 15A; an expansion of the
mass range where Orc[Ala11] would appear (Fig. 15B) reveals no
signals characteristic of Orc[Ala11], although other orcokinin fam-
ily peptides are abundant in the full MALDI-FT mass spectrum. We
detected peaks for Orc[1-11] in some, but not all, spectra. In the
replicated direct tissue MALDI-FTMS characterizations of localized
pieces of eyestalk ganglion tissues from multiple individuals, we
failed to detect signals characteristic of Orc[Ala11] in any spectra.
Because Orc[Ala11] has been reported in other H. americanus
neuroendocrine organs and tissues, including the supraesophageal
ganglion (SoG/brain) [4,30], pericardial organ (PO) [6], and the adult
and embryonic stomatogastric ganglion (STG) [4,23], we evaluated
the direct tissue MALDI-FT mass spectra of these organs and tis-
sues, as well as H. americanus commissural ganglia (CoG). We  again
characterized tissues derived from a minimum of three individ-
uals to determine if sampling variability or differences between
individuals could be responsible for our inability to detect puta-
tive Orc[Ala11]. Furthermore, we collected between three and ten
spectra from different regions of each MALDI sample to account
for heterogeneity within each sample. For the brain and POs, we
also analyzed multiple samples of tissue that were dissected from
different locations from the larger sample. CoGs were analyzed in
their entirety or split into two pieces prior to analysis, while the
entire STG was  co-crystallized with matrix. We  also characterized
the brain from a juvenile lobster. Representative spectra from the
tissues analyzed in our laboratory are shown in Fig. 15.
In previous studies, abundant signals for putative Orc[Ala11] and
Orc[1-11] were detected by direct tissue analysis of small pieces
of tissue dissected from the H. americanus PO [6]. Orc[Ala11] and
Orc[1-11] were found with other orcokinin family peptides in a
long ﬁber that projects along the crustacean muscle and into the
heart. In this study, MALDI samples were prepared by washing
the tissues in acidiﬁed methanol followed by co-crystallization
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Fig. 15. Direct tissue MALDI-FT mass spectra of H. americanus neuroendocrine organs and tissue. Each spectrum contains an expansion showing the region where m/z
1270.56  and 1253.54 ([M+H]+ and [MH−NH3]+ from putative Orc[Ala11]) would appear, if detected. (A) Spectrum from a SG freshly dissected from the eyestalk ganglion. (B)
An  expansion of spectrum (A) showing a peak for VYGPRDIANLY at m/z 1280.66, but no detectable signals for Orc[Ala11]. (C) Spectrum from a small piece of freshly dissected PO
from  a ﬁber projecting from the muscle to the heart. (D) An expansion of spectrum (C) showing peaks for VYGPRDIANLY at m/z 1280.66 and TNWNKFQGSWamide (m/z 1266.60),
but  no detectable signals for Orc[Ala11]. (E) Spectrum from a small piece of freshly dissected brain tissue from an adult lobster. (F) An expansion of spectrum (E) showing peaks
for  VYGPRDIANLY at m/z 1280.66, TNWNKFQGSWamide (m/z 1266.60), and pQDLDHVFLRFamide (m/z 1271.65), but no detectable signals for Orc[Ala11]. (G) Spectrum from a
small  piece of freshly dissected brain tissue from a juvenile lobster. (H) An expansion of spectrum (G) showing peaks for VYGPRDIANLY at m/z 1280.66, TNWNKFQGSWamide
(m/z  1266.60), and pQDLDHVFLRFamide (m/z 1271.65), but no detectable signals for Orc[Ala11]. (I) Spectrum from a freshly dissected STG. (J) An expansion of spectrum
(I)  showing peaks for VYGPRDIANLY at m/z 1280.66, TNWNKFQGSWamide (m/z 1266.60), pQDLDHVFLRFamide (m/z 1271.65), and STNWSSLRSAWamide (m/z 1293.63),
but  no detectable signals for Orc[Ala11]. (K) Spectrum from a freshly dissected STG. (L) An expansion of spectrum (K) showing peaks for VYGPRDIANLY at m/z 1280.66,
TNWNKFQGSWamide (m/z 1266.60), and pQDLDHVFLRFamide (m/z 1271.65), but no detectable signals for Orc[Ala11]. All samples were prepared using a fructose tissue
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Mash  and co-crystallization using DHB in acetonitrile as the matrix; conditions w
ncluding APSGFLGMRamide (CabTRP) and VYRKPPFNGSIFamide (Val1-SIFamide) a
ith DHB in 50% methanol [6]. In our investigations, we  excluded
ethanol from the sample preparation, washed tissues in fructose,
nd co-crystallized with DHB in acetonitrile prior to MALDI-FTMS
nterrogation. A representative PO spectrum from our analysis of
amples along the long ﬁbrous projection between the muscle
nd heart (Fig. 15C and D) shows strong signals from orcokinin
amily peptides. In agreement with the mass spectrum published
y Li and co-workers [6], which was dominated by signals from
rcokinin family peptides, we consistently detected peaks for the
rcokinin family peptides [Asn13], [His13], [Val13], Orc[1-12], SSED-
DRLGFGFN, FDAFTTGFGHN, and VYGPRDIANLY, all with massptimized for m/z 1500. Spectra were calibrated using known peptide peaks [42],
34.4927 and m/z 1423.7845, respectively.
measurement errors of less than 5 ppm. Furthermore, we  detected
Orc[1-11] in some, but not all, spectra; however, we failed to detect
signals for Orc[Ala11] in spectra for any of the PO tissues we exam-
ined.
Signals for putative Orc[Ala11] and Orc[1-11] were also detected
in H. americanus brain tissues through the analysis of tissue extracts
[30] and using direct tissue analyses [4,30], where either saturated
DHB in water [30] or acidiﬁed methanol [4] were used to wash tis-
sue samples and tissue samples were co-crystallization with DHB in
50% methanol. We have carried out the extraction of H. americanus
brain tissues using CD3OD in our extraction solvent and found only
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vidence for Orc[1-11]-OMe (trideuterated; data not shown). In our
irect tissue investigations, we excluded methanol from the sample
reparation, and analyzed small samples of brain tissues from adult
n > 4) and juvenile (n = 2) lobsters. Representative spectra from an
dult H. americanus brain (Fig. 15E and F) and from a juvenile brain
Fig. 15G and H) show complements of peptides similar to those
etected by the Li group [4,30], including abundant signals from
al1-SIF and the orcokinin family peptides [Asn13], [His13], [Val13],
rc[1-12], SSEDMDRLGFGFN, FDAFTTGFGHN, and VYGPRDIANLY,
ll with mass measurement errors of less than 5 ppm. A careful
xamination of the mass range where putative Orc[Ala11] should
ppear (Fig. 15F and H) shows two peptides, TNWNKFQGSWamide
m/z 1266.60) and pQDLDHVFLRFamide (m/z 1271.65), which had
een detected in the previous work [4,30]. While we  did detect
eak signals for Orc[1-11] in a few spectra, we did not detect signals
or Orc[Ala11] in spectra for any of the brain tissues we examined.
We also examined direct tissue spectra for the STG and CoG, two
dditional nervous system ganglia. Signals for putative Orc[Ala11]
nd Orc[1-11] were previously reported in H. americanus STG tis-
ues using direct tissue analyses [4,23], where acidiﬁed methanol
as used to wash tissue samples and the tissue samples were
o-crystallization with DHB in 50% methanol. In our direct tissue
nvestigations of these ganglia, we once again excluded methanol
rom the sample preparation. A representative spectrum from
n STG (Fig. 15I and J) shows complements of peptides similar
o those detected by the Li group [4,23], including an abundant
ignal from Val1-SIF. An examination of the mass range where
utative Orc[Ala11] should appear (Fig. 15I and J) shows three pep-
ides, TNWNKFQGSWamide (m/z 1266.60), pQDLDHVFLRFamide
m/z 1271.65), and STNWSSLRSAWamide (m/z 1293.63), which
ave been detected in the previous work [4,23]; however, we did
ot detect signals for Orc[Ala11] in spectra of any STG tissues we
xamined. We  also failed to detect signals for Orc[Ala11] in the
ALDI-FTMS spectra for any CoGs (Fig. 15K and L), where we have
xamined samples from over 20 individuals.
. Discussion
For any study aspiring to characterize the endogenous com-
onents of a biological system, an underlying assumption is that
he sampling and analysis approach will leave the sample in an
naltered state. Our results document a highly speciﬁc neuro-
eptide structural alteration, namely the combined truncation and
-terminal methylation of orcokinin family peptides, that occurs
nly when biological components of a crustacean tissue sample are
resent in an acidiﬁed methanolic extraction solvent.
.1. The peptide NFDEIDRSGFG-OMe is produced from full-length
rcokinin peptides via methanolysis in acidiﬁed, methanolic
xtraction solvents
We  used SORI-CID (product ion mass spectra from [M+H]+
nd y5 ions) to identify an m/z 1270.57 peptide detected in
. americanus eyestalk tissue extracts as NFDEIDRSGFG-OMe,
ot isobaric, previously identiﬁed NFDEIDRSGFA, based upon the
omparisons with standard-derived SORI-CID reference spectra.
urthermore, we used LC/MS to show that the extraction-derived
eptide eluted with the same retention time as an Orc[1-11]-
Me, not Orc[Ala11], standard. We  used extraction with CD3OD
o show that methanol from the solvent is the source of the
ingle methyl group found in the m/z 1270.57 peptide detected
n H. americanus eyestalk tissue extracts, and applied Q-TOF-
ID to show that the added methyl group is found only at the
-terminus of the peptide, Orc[1-11]-OMe. A second truncated,
-terminally methylated peptide, SSEDMDRLGFG-OMe, was  alsos 46 (2013) 108–125
identiﬁed based upon mass measurements and labeling experi-
ments with CD3OD.
Our work provides evidence to support the role of a tis-
sue component, presumably an enzyme, in the production of
the Orc[1-11]-OMe product. Our evidence supporting enzymatic
participation in the formation of Orc[1-11]-OMe includes the fol-
lowing. First, the speciﬁcity associated with the observed single
methylation at the peptide C-terminus is at odds with the outcome
expected if a chemical acid-catalyzed esteriﬁcation were responsi-
ble for methylation. The peptide sequence contains three additional
targets for methylation (one glutamate and two aspartate residues)
and, of the four methylation sites on the peptide, the glutamate
residue is expected to be the favored target for acid-catalyzed
methylation [17]. Second, we  found no evidence for any products of
acid-catalyzed esteriﬁcation when full-length (NFDEIDRSGFGFN)
and truncated (NFDEIDRSGFG) peptide standards were incubated
in the acidic methanolic extraction solvent at room temperature for
24 h. Third, we found evidence to support the conversion of NFDEI-
DRSGFGFA, a full-length, non-native orcokinin family peptide, to
Orc[1-11]-OMe when eyestalk tissues were mixed with the peptide
and extraction solvent. This conversion involved peptide truncation
(net loss of FA), with C-terminal methylation. This experiment pro-
vided evidence showing that tissue components play a critical role
in Orc[1-11]-OMe formation and documented the conversion of a
full-length orcokinin family peptides to the truncated, methylated
Orc[1-11]-OMe product. Fourth, we  observed signiﬁcant, though
not complete, inhibition of Orc[1-11]-OMe and Orc[1-11] produc-
tion when an enzyme inhibitor cocktail was  incorporated in the
extraction protocol and, more deﬁnitively, found that insertion of
the tissue/extraction solvent mixture into a boiling water bath pro-
vided the most effective method for preventing Orc[1-11]-OMe
and Orc[1-11] formation. These two enzyme-deactivation meth-
ods provided the most speciﬁc evidence that an enzymatic, not
chemical, reaction is responsible for the observed peptide conver-
sion. Additionally, when we  reduced the percentage of water in
the extraction solvent, we observed that the formation of Orc[1-
11]-OMe was  reduced, but not eliminated. The reduced production
of Orc[1-11]-OMe may  reﬂect an inhibition of enzymatic activ-
ity if the higher percentage of methanol in the solvent denatured
the enzyme or otherwise yielded conditions that impeded enzy-
matic activity. Fifth, we  found that eliminating acetic acid from the
extraction solvent resulted in enhanced levels of the Orc[1-11] pep-
tide, while Orc[1-11]-OMe was no longer detected. This supported
work showing that enzymatic methanolysis is favored over hydrol-
ysis for enzymes functioning under more acidic pH conditions [3].
Finally, we also demonstrated that, under conditions where the
pH is reduced, methanol can act as a competing nucleophile to
yield a C-terminally methylated product using the serine protease,
trypsin.
4.2. Orc[Ala11] is not detected in H. americanus tissues using
direct tissue analyses or when eyestalk tissues are analyzed using
three independent extraction-based approaches
Because previously reported Orc[Ala11] is isobaric with the
extraction artifact, Orc[1-11]-OMe, we  attempted to determine if
low abundance levels of Orc[Ala11] were obscured and undetected
in our analyses with methanol. To address these concerns, we car-
ried out three independent extraction-based analyses of eyestalk
tissues, namely, (1) MALDI-FTMS analyses of eyestalk ganglion
extracts using non-methanolic solvent systems (acidiﬁed acetone
and saturated DHB), (2) HPLC Chip–nanoESI Q-TOF MS  analyses
of pooled eyestalk extracts, all heat-treated to deactivate enzymes
and extracted using a solvent composition that was  used in previ-
ous studies, and (3) MALDI-FTMS of sinus gland tissues extracted
with full methyl esteriﬁcation, which provides an additional way
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o distinguish Orc[Ala11] and Orc[1-11]-OMe. These three inde-
endent approaches failed to show any evidence to support the
resence of Orc[Ala11] as a peptide endogenous to the lobster.
To determine if we were able to detect Orc[Ala11] by direct tis-
ue analyses, we analyzed additional eyestalk tissues and other H.
mericanus neuronal glands and tissues (PO, brain, STG, and CoG)
y direct tissue MALDI-FTMS, where methanol is not used in any
teps of our tissue preparation protocol. All of our measurements,
hich often included multiple sub-samples dissected from larger
issues (PO and brain), and which represented measurement from
 minimum of three individuals and a maximum of greater than 20
ndividuals for SG and CoG samples, failed to show any evidence of
eaks characteristic of Orc[Ala11] in any spectra.
While it is impossible to prove that a peptide is not present in
n organism, our best efforts, using direct tissue analyses and three
ndependent extraction-based approaches, failed to show signals
upporting prior work identifying Orc[Ala11] as a peptide endoge-
ous to the lobster.
.3. The observed truncation with C-terminal methylation calls
nto question some prior neuropeptide sequence identiﬁcations
here acidic methanolic solutions are used for extraction or direct
issue preparations
Acidiﬁed methanol has been used as the extraction solvent
f choice in many previous investigations of invertebrate neu-
opeptides [1,10,14,21,35,39]. For the extraction of crustacean
issues, research groups have commonly used methanolic solvent
ystems composed of 90% methanol, 1% water [10,14,21,39] or
% water [46], and acetic acid. Furthermore, for many MALDI-
ased analyses of crustacean tissues, acidiﬁed methanol has been
ommonly used as a tissue washing protocol and methanol is a
omponent of the DHB matrix solutions [16,26,29,30].
Orcokinin family peptides have been characterized in many
rustacean species. Of the many characterized, full-length
rcokinins [7], glycine, not alanine, is found exclusively at the 11th
osition in the sequence. Although genomic data for crustaceans
s sparse, the available information documents no genes encod-
ng full-length orcokinins with Ala11; furthermore, no genes have
een found for any truncated orcokinin variants. This sequence
nalysis, coupled with our demonstration that isobaric Orc[1-11]-
Me is an extraction artifact, has led us to question the identity
f previously published truncated orcokinin family peptides with
n alanine, not glycine, at the 11th position. This concern has been
upported by our analysis of H. americanus tissues using approaches
hat either exclude methanol or permit differentiation of Orc[1-11]-
Me/Orc[Ala11], where we failed to ﬁnd any evidence of putative
rc[Ala11].
The truncated orcokinin, Orc[Ala11], was ﬁrst reported by Huy-
rechts et al. as a novel peptide de novo sequenced from the Jonah
rab, C. borealis [21]. For that study, brain and thoracic ganglion tis-
ues from 50 animals were extracted in methanol:water:acetic acid
90:9:1) and peptides were sequenced using ESI-Q-TOF MS/MS. As
as the case for H. americanus, this peptide sequence, with an ala-
ine appearing as the 11th residue, is at odds with the sequences of
ull-length C. borealis orcokinin peptides, which have been estab-
ished by many MS  studies [21,32]. We  suggest that the peptide
eported by Huybrechts et al. is, in fact, Orc[1-11]-OMe; this asser-
ion is supported by work carried out in our laboratory, where
e have evidence for the detection of Orc[1-11]-OMe in C. bore-
lis brain tissue extracts (data not shown), but not for any directly
nalyzed C. borealis tissues (CoG, SG, PO, brain) (data not shown).
ecause alanine (A) is isobaric with methylation at a C-terminal
lycine residue (G-OMe), this distinction would not have been
evealed from mass measurements. Furthermore, the MS/MS  tech-
ique used for de novo peptide sequencing in the Huybrechts et al.s 46 (2013) 108–125 123
study would not have provided any obvious ﬂags to distinguish the
C-terminal alanine from G-OMe.
The orcokinins NFDEIDRSGFA, SSEDMDRLGFA, and NFDEI-
DRSSFA, all with an alanine as the 11th residue and all detected
in tissues that had been analyzed following extraction with
acidiﬁed methanol, have been reported in other publications
[15,16,21,30–32]. In summary, our work calls into question the
identiﬁcation of these truncated peptides, which may have Gly-
OMe, not Ala, at the C-terminus.
4.4. The C-terminal Gly-OMe motif may be misidentiﬁed as
Ala-OH
A unique issue for the in vitro modiﬁcation detected in this study
is the localized methylation at the C-terminus. Because the Gly-
OMe  modiﬁcation is isobaric with Ala-OH, this structural change
is not detectable via mass measurements. In this study, where
the y5 fragment ion was  isolated and dissociated, the arginine-
containing, singly protonated y5 precursors (protonated RSGFGFA
or RSGFG-OMe, respectively) yielded MS/MS  spectra sensitive
to the methyl-esteriﬁed C-terminus. Speciﬁcally, we observed a
[b4+H2O]+ product ion when the C-terminus had a free carboxyl
group (for Orc[Ala11]), and that diagnostic ion was missing when
the C-terminus was  methyl esteriﬁed (for Orc[1-11]-OMe). In con-
trast, the MS/MS  spectra generated on our Q-TOF instrument were
insensitive to the structural difference, and this approach could
not be used for distinguishing the two peptide sequences. Because
MS/MS  spectra may  not provide the speciﬁc, diagnostic information
needed to distinguish the peptide sequences, and because stan-
dards are not always available, other measures, such as running
extraction solvent controls with isotopically labeled solvents, may
be needed to distinguish this extraction artifact.
4.5. Hypotheses regarding the formation of Orc[1-11]-OMe
Protease-catalyzed reactions have been exploited by chemists
to carry out a variety of transformations in nonaqueous solvents
[2], including C-terminal peptide esteriﬁcations [3,22,33,34]. Most
enzymes exploited for this purpose are serine or cysteine pro-
teases, which form reactive acyl-enzyme intermediates that can
be attacked by a competing nucleophile, such as methanol.
In considering mechanisms that may  be responsible for the pro-
duction of Orc[1-11]-OMe and SSEDMDRLGFG-OMe, we note that
the longer precursors to these modiﬁed orcokinin family peptides
are not amidated at the C-terminus. Most bioactive neuropeptides
are C-terminally amidated to prevent proteolytic degradation;
therefore, the orcokinin peptides would be expected to be more
susceptible to both enzymatic degradation and enzyme-mediated
methylation. Additionally, while other C-terminally truncated
orcokinins (predominantly Orc[1-12] and Orc[1-11]), have been
detected in our investigations [10] and by other researchers
[4,6,27,40], the C-terminal methylations detected for Orc[1-11]-
OMe  and SSEDMDRLGFG-OMe have only been associated with
Gly11. This implies that there is something unique about this amino
acid (G) or the amino acid sequence proximate to this location that,
in some way, enhances selectivity toward methanolysis. Finally, the
glycine-phenylalanine (GF) motif at positions 11 and 12 are highly
conserved elements of crustacean orcokinin sequences, which also
may  signify that this motif is important to neuropeptide function
or processing.
Based on this information, we  speculate that methanol could
participate in either exo- or endopeptidase-mediated path-
ways leading to the production of Orc[1-11]-OMe, as well as
SSEDMDRLGFG-OMe, from full-length orcokinin family peptides.
An important element of this mechanism is the acidity of the sol-
vent system, which can promote enzymatic methanolysis over
124 E.A. Stemmler et al. / Peptides 46 (2013) 108–125
Fig. 16. Pathways that may  result in C-terminal methanolysis to form Orc[1-11]-OMe. Pathways A and B include methanol as a competing nucleophile that attacks the
acyl-enzyme intermediate formed by most serine endo- and exoproteases. Pathway A depicts possible reactions of an exopeptidase; pathway B depicts the pathway for an
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ropeptide complement of the stomatogastric ganglion and brain in the adult
and  embryonic lobster, Homarus americanus. J Neurochem 2008;105:690–702.
[5] Chen GQ, Liu H, Wang XD, Li ZL. In vitro methylation by methanol: proteomic
screening and prevalence investigation. Anal Chim Acta 2010;661:67–75.ndopeptidase. The high abundance of Orc[1-11]-OMe may  result from the action 
lycine  residue. Solution pH may  play a role in partitioning between hydrolysis (pr
avoring methanolysis.
ydrolysis [3]. One hypothesis, pathway A in Fig. 16, would involve
-terminal proteolysis of full-length orcokinin family peptides by
n exopeptidase. Carboxypeptidases play an important role in the
onversion of neuropeptide preprohormones into active neuro-
eptides, and these enzymes may  be responsible for the production
f truncated orcokinin peptides. For pathway A, selective detec-
ion of Orc[1-11]-OMe, but not Orc[1-12]-OMe, would require a
inetic effect favoring water addition (hydrolysis) to form Orc[1-
2], with methanol able to compete effectively following loss of
he phenylalanine (F) residue. A second hypothesis, pathway B in
ig. 16, invokes an endopeptidase with speciﬁcity toward cleavage
etween the Gly-Phe peptide bond. Again, to rationalize produc-
ion of Orc[1-11]-OMe, methylation would occur in conjunction
ith the enzymatic cleavage of the peptide bond. Finally, we note
hat an amidated orcokinin, NFDEIDRSGFamide (Orc[1-10]-NH2),
as been reported in the literature for H. americanus [30] and
etected in our lab (data not shown). In this peptide, the C-terminal
ly11 residue (methylated in Orc[1-11]-OMe) is the residue tar-
eted by the peptidylglycine enzymes responsible for converting
ly11 into an amide group. The speciﬁcity associated with methyla-
ion of the Gly11 residue may  be related to formation of an activated
ntermediate that is formed in the possible conversion of Gly11 to
he amidated, Orc[1-10]-NH2 product. Further experimentation is
learly needed to determine if any of these speculations about the
ighly speciﬁc conversion observed in this study have merit.
. Conclusions
The truncated and C-terminally modiﬁed orcokinins,
FDEIDRSGFG-OMe (Orc[1-11]-OMe) and SSEDMDRLGFG-OMe
ere identiﬁed in eyestalk tissue extracts and the conditions
esponsible for production were explored using mass spec-
rometry. We  found that the truncation with C-terminal methyl
steriﬁcation occurs as a result of the extraction procedure, but
he reaction is not a simple chemical acid-catalyzed esteriﬁca-
ion. Experiments with enzyme inhibitors and the use of heat
or enzyme deactivation supported an enzymatically mediated
onversion of full-length orcokinins to the truncated, methylatedeciﬁc dipeptidase or an elevated reaction rate associate with methanolysis at the
g Orc[1-11]) and methanolysis (producing Orc[1-11]-OMe), with lower pH values
NFDEIDRSGFG-OMe (Orc[1-11]-OMe) and SSEDMDRLGFG-OMe
product. These products were not detected when tissues were
analyzed directly. This study should heighten awareness regarding
unexpected structural perturbations that may  occur when
neuropeptides are extracted from biological tissues.
Acknowledgements
This project was supported by the National Science Founda-
tion MRI-0116416 (E.A.S), CHE-1126657 (E.A.S.), and IBN-0111040
(P.S.D.); National Center for Research Resources (5P20RR016463-
12) and the National Institute of General Medical Sciences (8 P20
GM103423-12) from the National Institutes of Health, institutional
funds provided to A.E.C by MDIBL, the Surdna Foundation (fel-
lowship to D.A.P.); the Merck Foundation and Henry L. and Grace
Doherty Charitable Foundation Coastal Studies Research Fellow-
ship (to E.B.). We  thank Rachel Ackerman for her MALDI-FTMS
analysis of H. americanus brain tissues from juvenile lobsters and
Peter Tracy for his assistance with the collection and LC–MS anal-
ysis of extracted eyestalk tissues.
References
[1] Baggerman G, Cerstiaens A, De Loof A, Schoofs L. Peptidomics of
the  larval Drosophila melanogaster central nervous system. J Biol Chem
2002;277:40368–74.
[2] Bordusa F. Proteases in organic synthesis. Chem Rev 2002;102:4817–67.
[3] Breddam K, Widmer F, Johansen JT. Carboxypeptidase Y catalyzed C-terminal
modiﬁcations of peptides. Carlsberg Res Commun 1981;46:121–8.
[4] Cape SS, Rehm KJ, Ma M, Marder E, Li LJ. Mass spectral comparison of the neu-[6] Chen R, Jiang X, Prieto Conaway MC,  Mohtashemi I, Hui L, Viner R, et al. Mass
spectral analysis of neuropeptide expression and distribution in the nervous
system of the lobster Homarus americanus. J Proteome Res 2010;9:818–32.
[7] Christie AE, Stemmler EA, Dickinson PS. Crustacean neuropeptides. Cell Mol
Life Sci 2010;67:4135–69.
eptide
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[E.A. Stemmler et al. / P
[8] Christie AE, Stemmler EA, Peguero B, Messinger DI, Provencher HL, Scheerlinck
P,  et al. Identiﬁcation, physiological actions, and distribution of VYRKPPFNGSI-
Famide (Val(1)-SIFamide) in the stomatogastric nervous system of the
American lobster Homarus americanus. J Comp Neurol 2006;496:406–21.
[9] Colgrave ML,  Xi L, Lehnert SA, Flatscher-Bader T, Wadensten H, Nilsson A,
et al. Neuropeptide proﬁling of the bovine hypothalamus: thermal stabiliza-
tion is an effective tool in inhibiting post-mortem degradation. Proteomics
2011;11:1264–76.
10] Dickinson PS, Stemmler EA, Barton EE, Cashman CR, Gardner NP, Rus S,
et  al. Molecular, mass spectral, and physiological analyses of orcokinins and
orcokinin precursor-related peptides in the lobster Homarus americanus and
the  crayﬁsh Procambarus clarkii.  Peptides 2009;30:297–317.
11] Dickinson PS, Wiwatpanit T, Gabranski ER, Ackerman RJ, Stevens JS, Cash-
man  CR, et al. Identiﬁcation of SYWKQCAFNAVSCFamide: a broadly conserved
crustacean C-type allatostatin-like peptide with both neuromodulatory and
cardioactive properties. J Exp Biol 2009;212:1140–52.
12] Dowell JA, Vander Heyden W,  Li L. Rat neuropeptidomics by LC–MS/MS and
MALDI-FTMS: enhanced dissection and extraction techniques coupled with 2D
RP-RP HPLC. J Proteome Res 2006;5:3368–75.
13] Fricker LD, Lim J, Pan H, Che F-Y. Peptidomics: identiﬁcation and quantiﬁca-
tion of endogenous peptides in neuroendocrine tissues. Mass Spectrom Rev
2006;25:327–44.
14] Fu Q, Christie AE, Li L. Mass spectrometric characterization of crustacean hyper-
glycemic hormone precursor-related peptides (CPRPs) from the sinus gland of
the  crab, Cancer productus. Peptides 2005;26:2137–50.
15] Fu Q, Goy MF,  Li L. Identiﬁcation of neuropeptides from the decapod crustacean
sinus glands using nanoscale liquid chromatography tandem mass spectrom-
etry. Biochem Biophys Res Commun 2005;337:765–78.
16] Fu Q, Kutz KK, Schmidt JJ, Hsu YWA, Messinger DI, Cain SD, et al. Hor-
mone complement of the Cancer productus sinus gland and pericardial
organ: an anatomical and mass spectrometric investigation. J Comp Neurol
2005;493:607–26.
17] Haebel S, Albrecht T, Sparbier K, Walden P, Korner R, Steup M.  Electrophoresis-
related protein modiﬁcation: alkylation of carboxy residues revealed by mass
spectrometry. Electrophoresis 1998;19:679–86.
18] Hopkins PM.  The eyes have it: a brief history of crustacean neuroendocrinology.
Gen Comp Endocrinol 2012;175:357–66.
19] Hui L, Xiang F, Zhang Y, Li L. Mass spectrometric elucidation of the neuropep-
tidome of a crustacean neuroendocrine organ. Peptides 2012;36:230–9.
20] Hummon AB, Amare A, Sweedler JV. Discovering new invertebrate neuro-
peptides using mass spectrometry. Mass Spectrom Rev 2006;25:77–98.
21] Huybrechts J, Nusbaum MP,  Bosch LV, Baggerman G, De Loof A, Schoofs L. Neu-
ropeptidomic analysis of the brain and thoracic ganglion from the Jonah crab,
Cancer borealis. Biochem Biophys Res Commun 2003;308:535–44.
22] Ingalls RG, Squires RG, Butler LG. Reversal of enzymic hydrolysis. Rate and
extent of ester synthesis as catalyzed by chymotrypsin and subtilisin Carlsberg
at  low water concentrations. Biotechnol Bioeng 1975;17:1627–37.
23] Jiang X, Chen R, Wang J, Metzler A, Tlusty M,  Li L. Mass spectral charting
of  neuropeptidomic expression in the stomatogastric ganglion at multiple
developmental stages of the lobster Homarus americanus. ACS Chem Neurosci
2012;3:439–50.
24] Jung SY, Li YH, Wang Y, Chen Y, Zhao YM,  Qin J. Complications in the assign-
ment of 14 and 28 Da mass shift detected by mass spectrometry as in vivo
methylation from endogenous proteins. Anal Chem 2008;80:1721–9.
25] Klibanov AM.  Why  are enzymes less active in organic solvents than in water.
Trends Biotechnol 1997;15:97–101.
26] Kutz KK, Schmidt JJ, Li L. In situ tissue analysis of neuropeptides by MALDI FTMS
in-cell accumulation. Anal Chem 2004;76:5630–40.
27] Li L, Pulver SR, Kelley WP,  Thirumalai V, Sweedler JV, Marder E. Orcokinin pep-
tides in developing and adult crustacean stomatogastric nervous system and
pericardial organs. J Comp Neurol 2002;444:227–44.28] Li L, Sweedler JV. Peptides in the brain: mass spectrometry-based measurement
approaches and challenges. Annu Rev Anal Chem 2008;1:451–83.
29] Ma  M,  Bors EK, Dickinson ES, Kwiatkowski MA,  Sousa GL, Henry RP, et al. Char-
acterization of the Carcinus maenas neuropeptidome by mass spectrometry and
functional genomics. Gen Comp Endocrinol 2009;161:320–34.
[
[s 46 (2013) 108–125 125
30] Ma  M,  Chen R, Sousa GL, Bors EK, Kwiatkowski MA, Goiney CC, et al. Mass spec-
tral characterization of peptide transmitters/hormones in the nervous system
and neuroendocrine organs of the American lobster Homarus americanus. Gen
Comp Endocrinol 2008;156:395–409.
31] Ma  MM,  Bors EK, Dickinson ES, Kwiatkowski MA,  Sousa GL,  Henry RP, et al. Char-
acterization of the Carcinus maenas neuropeptidome by mass spectrometry and
functional genomics. Gen Comp Endocrinol 2009;161:320–34.
32] Ma  MM,  Wang JH, Chen RB, Li LJ. Expanding the crustacean neuropep-
tidome using a multifaceted mass spectrometric approach. J Proteome Res
2009;8:2426–37.
33] Nuijens T, Cusan C, Kruijtzer JAW, Rijkers DTS, Liskamp RMJ, Quaedﬂieg P. Ver-
satile selective alpha-carboxylic acid esteriﬁcation of N-protected amino acids
and peptides by alcalase. Synthesis-Stuttgart 2009;80:9–14.
34] Park H, Chi Y-M. Distinction between the inﬂuence of dielectric constant and
of  methanol concentration on trypsin-catalyzed hydrolysis and methanolysis.
J  Microbiol Biotechnol 1998;8:656–62.
35] Predel R, Kellner R, Rapus J, Gade G. Allatostatins from the retrocerebral
complex and antennal pulsatile organ of the American cockroach: structural
elucidation aided by matrix-assisted laser desorption/ionization-time-of-ﬂight
mass spectrometry. Regul Pept 1999;82:81–9.
36] Roepstorff P. Proposal for a common nomenclature for sequence ions in mass
spectra of peptides. Biomed Environ Mass Spectrom 1984;11:601.
37] Romanova EV, Rubakhin SS, Sweedler JV. One-step sampling, extraction, and
storage protocol for peptidomics using dihydroxybenzoic acid. Anal Chem
2008;80:3379–86.
38] Russell WK,  Park Z-Y, Russell DH. Proteolysis in mixed organic-aqueous solvent
systems: applications for peptide mass mapping using mass spectrometry. Anal
Chem 2001;73:2682–5.
39] Sithigorngul P, Saraithongkum W,  Longyant S, Panchan N, Sithigorngul W,  Pet-
som  A. Three more novel FMRFamide-like neuropeptide sequences from the
eyestalk of the giant freshwater prawn Macrobrachium rosenbergii. Peptides
2001;22:191–7.
40] Skiebe P, Dreger M,  Borner J, Meseke M,  Weckwerth W.  Immunocytochem-
ical and molecular data guide peptide identiﬁcation by mass spectrometry:
orcokinin and orcomyotropin-related peptides in the stomatogastric nervous
system of several crustacean species. Cell Mol  Biol 2003;49:851–71.
41] Stangier J, Hilbich C, Burdzik S, Keller R. Orcokinin: a novel myotropic pep-
tide from the nervous system of the crayﬁsh, Orconectes limosus. Peptides
1992;13:859–64.
42] Stemmler EA, Cashman CR, Messinger DI, Gardner NP, Dickinson PS, Christie
AE. High-mass-resolution direct-tissue MALDI-FTMS reveals broad conser-
vation of three neuropeptides (APSGFLGMRamide, GYRKPPFNGSIFamide and
pQDLDHVFLRFamide) across members of seven decapod crustaean infraorders.
Peptides 2007;28:2104–15.
43] Stemmler EA, Provencher HL, Guiney ME,  Gardner NP, Dickinson PS. Matrix-
assisted laser desorption/ionization Fourier transform mass spectrometry
for  the identiﬁcation of orcokinin neuropeptides in crustaceans using
metastable decay and sustained off-resonance irradiation. Anal Chem 2005;77:
3594–606.
44] Svensson M,  Boren M,  Skold K, Faelth M,  Sjoegren B, Andersson M,  et al. Heat sta-
bilization of the tissue proteome: a new technology for improved proteomics.
J  Proteome Res 2009;8:974–81.
45] Thorne GC, Ballard KD, Gaskell SJ. Metastable decomposition of peptide [M+H]+
ions via rearrangement involving loss of the C-terminal amino-acid residue. J
Am Soc Mass Spectrom 1990;1:249–57.
46] Torfs P, Nieto J, Cerstiaens A, Boon D, Baggerman G,  Poulos C, et al. Pyrokinin
neuropeptides in a crustacean: isolation and identiﬁcation in the white shrimp
Penaeus vannamei. Eur J Biochem 2001;268:149–54.
47] Wysocki VH, Tsaprailis G, Smith LL, Breci LA. Special feature: Commentary –
Mobile and localized protons: a framework for understanding peptide dissoci-
ation. J Mass Spectrom 2000;35:1399–406.48] Xing G, Zhang JM,  Chen Y, Zhao YM.  Identiﬁcation of four novel types of in vitro
protein modiﬁcations. J Proteome Res 2008;7:4603–8.
49] Yin P, Hou X, Romanova EV, Sweedler JV. Neuropeptidomics: mass
spectrometry-based qualitative and quantitative analysis. Methods Mol  Biol
2011;789:223–36.
